{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:50:26Z","timestamp":1793742626229,"version":"4.6.1"},"reference-count":319,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470182"],"award-info":[{"award-number":["82470182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017532","name":"Medical Technology and Education of Zhejiang Province of China","doi-asserted-by":"publisher","award":["2024KY392"],"award-info":[{"award-number":["2024KY392"]}],"id":[{"id":"10.13039\/501100017532","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hyaluronidase (HAase), a family of enzymes critical for regulating physiological and pathological states, catalyzes the degradation of hyaluronic acid (HA), a key component of the extracellular matrix (ECM). By modulating ECM composition and cellular signaling pathways, HAase plays a pivotal role in diverse biological processes, including wound healing, tissue regeneration, and tumor progression. This review systematically elucidates the classification, biological sources, structural diversity, and catalytic mechanisms of HAase, emphasizing its dynamic involvement in disease pathogenesis and diagnostic potential.\u00a0Furthermore, the article explores innovative therapeutic strategies centered on HAase modulation. HAase inhibitors emerge as promising tools for maintaining HA homeostasis, with implications in anti-inflammatory, antimicrobial, and antitumor therapies by blocking excessive HA degradation. Concurrently, HAase-mediated drug delivery systems represent a paradigm shift in overcoming biological barriers, enhancing bioavailability, and optimizing therapeutic outcomes through ECM remodeling. Notably, the synergy between HAase and immunotherapeutic modalities, such as checkpoint inhibitors and adoptive cell therapies, demonstrates synergistic antitumor effects by reshaping the tumor microenvironment (TME) and augmenting immune cell infiltration. Nevertheless, numerous challenges persist in the clinical application of hyaluronidase, including its immunogenicity, safety, application limitations and ethical considerations. This review synthesizes current research advances and unresolved issues, integrating molecular insights with translational perspectives, aiming to provide a more comprehensive and in-depth understanding of hyaluronidase and to advance clinical therapeutic strategies for hyaluronidase.<\/jats:p>","DOI":"10.1186\/s43556-025-00299-y","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T23:02:59Z","timestamp":1752274979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets"],"prefix":"10.1186","volume":"6","author":[{"given":"Jiamin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7772-220X","authenticated-orcid":false,"given":"Shibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"299_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-800092-2.00001-0","volume":"123","author":"CO McAtee","year":"2014","unstructured":"McAtee CO, Barycki JJ, Simpson MA. Emerging roles for hyaluronidase in cancer metastasis and therapy. Adv Cancer Res. 2014;123:1\u201334. https:\/\/doi.org\/10.1016\/B978-0-12-800092-2.00001-0.","journal-title":"Adv Cancer Res"},{"issue":"12","key":"299_CR2","doi-asserted-by":"publisher","first-page":"10296","DOI":"10.3390\/ijms241210296","volume":"24","author":"GN Iaconisi","year":"2023","unstructured":"Iaconisi GN, Lunetti P, Gallo N, Cappello AR, Fiermonte G, Dolce V, et al. Hyaluronic Acid: A Powerful Biomolecule with Wide-Ranging Applications\u2014A Comprehensive Review. Int J Mol Sci. 2023;24(12):10296. https:\/\/doi.org\/10.3390\/ijms241210296.","journal-title":"Int J Mol Sci"},{"key":"299_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2019.02.002","volume":"78\u201379","author":"S Garantziotis","year":"2019","unstructured":"Garantziotis S, Savani RC. Hyaluronan biology: A complex balancing act of structure, function, location and context. Matrix Bio. 2019;78\u201379:1\u201310. https:\/\/doi.org\/10.1016\/j.matbio.2019.02.002.","journal-title":"Matrix Bio"},{"key":"299_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112095","volume":"208","author":"M Sindelar","year":"2021","unstructured":"Sindelar M, Jilkova J, Kubala L, Velebny V, Turkova K. Hyaluronidases and hyaluronate lyases: From humans to bacteriophages. Colloids Surf B Biointerfaces. 2021;208: 112095. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112095.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"299_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1042\/BJ20101185","volume":"432","author":"V Lombard","year":"2010","unstructured":"Lombard V, Bernard T, Rancurel C, Brumer H, Coutinho PM, Henrissat B. A hierarchical classification of polysaccharide lyases for glycogenomics. Biochem J. 2010;432(3):437\u201344. https:\/\/doi.org\/10.1042\/BJ20101185.","journal-title":"Biochem J"},{"issue":"3","key":"299_CR6","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1021\/cr050247k","volume":"106","author":"R Stern","year":"2006","unstructured":"Stern R, Jedrzejas MJ. Hyaluronidases: Their genomics, structures, and mechanisms of action. Chem Rev. 2006;106(3):818\u201339. https:\/\/doi.org\/10.1021\/cr050247k.","journal-title":"Chem Rev"},{"key":"299_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114474","volume":"203","author":"J Zhao","year":"2024","unstructured":"Zhao J, Chen J, Li C, Xiang H, Miao X. Hyaluronidase overcomes the extracellular matrix barrier to enhance local drug delivery. Eur J Pharm Biopharm. 2024;203: 114474. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114474.","journal-title":"Eur J Pharm Biopharm"},{"key":"299_CR8","unstructured":"Duran-Reynals F. Exaltation de l\u2019activit\u00e9 du virus vaccinal par les extraits de certains organes. Compt Rend Soc biol. 1928;9:6\u20137. n.d."},{"key":"299_CR9","unstructured":"Chain E, Duthie ES. Identity of hyaluronidase and spreading factor. Br. J. Exp. Pathol. 1940;21(6):324. n.d."},{"key":"299_CR10","doi-asserted-by":"publisher","unstructured":"Wang W, Wang J, Li F. Hyaluronidase and Chondroitinase. In: Atassi MZ, editor. Protein Rev. 2016; p. 75\u201387. https:\/\/doi.org\/10.1007\/5584_2016_54.","DOI":"10.1007\/5584_2016_54"},{"issue":"21","key":"299_CR11","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.lfs.2007.02.037","volume":"80","author":"KS Girish","year":"2007","unstructured":"Girish KS, Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sci. 2007;80(21):1921\u201343. https:\/\/doi.org\/10.1016\/j.lfs.2007.02.037.","journal-title":"Life Sci"},{"key":"299_CR12","doi-asserted-by":"publisher","unstructured":"Meyer K. 11 Hyaluronidases. The Enzymes, vol. 5, Elsevier; 1971; p. 307\u201320. https:\/\/doi.org\/10.1016\/S1874-6047(08)60094-3.","DOI":"10.1016\/S1874-6047(08)60094-3"},{"issue":"3","key":"299_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0304-4165(94)90173-2","volume":"1200","author":"JA Cramer","year":"1994","unstructured":"Cramer JA, Bailey LC, Bailey CA, Miller RT. Kinetic and mechanistic studies with bovine testicular hyaluronidase. Biochim Biophys Acta. 1994;1200(3):315\u201321. https:\/\/doi.org\/10.1016\/0304-4165(94)90173-2.","journal-title":"Biochim Biophys Acta"},{"key":"299_CR14","doi-asserted-by":"publisher","unstructured":"Meyer K, Rapport MM. Hyaluronidases. Adv Enzymol Relat Subj Biochem. 1952; p. 199\u2013236. https:\/\/doi.org\/10.1002\/9780470122587.ch6.","DOI":"10.1002\/9780470122587.ch6"},{"issue":"4590","key":"299_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/180810b0","volume":"180","author":"A Linker","year":"1957","unstructured":"Linker A, Hoffman P, Meyer K. The hyaluronidase of the leech: an endoglucuronidase. Nature. 1957;180(4590):810\u20131. https:\/\/doi.org\/10.1038\/180810b0.","journal-title":"Nature"},{"key":"299_CR16","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1038\/srep04471","volume":"4","author":"P Jin","year":"2014","unstructured":"Jin P, Kang Z, Zhang N, Du G, Chen J. High-yield novel leech hyaluronidase to expedite the preparation of specific hyaluronan oligomers. Sci Rep. 2014;4:4471. https:\/\/doi.org\/10.1038\/srep04471.","journal-title":"Sci Rep"},{"issue":"4","key":"299_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jmb.2006.02.066","volume":"358","author":"DJ Rigden","year":"2006","unstructured":"Rigden DJ, Littlejohn JE, Joshi HV, de Groot BL, Jedrzejas MJ. Alternate structural conformations of Streptococcus pneumoniae hyaluronan lyase: insights into enzyme flexibility and underlying molecular mechanism of action. J Mol Biol. 2006;358(4):1165\u201378. https:\/\/doi.org\/10.1016\/j.jmb.2006.02.066.","journal-title":"J Mol Biol"},{"key":"299_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2022.108018","volume":"60","author":"Y-S Zhang","year":"2022","unstructured":"Zhang Y-S, Gong J-S, Yao Z-Y, Jiang J-Y, Su C, Li H, et al. Insights into the source, mechanism and biotechnological applications of hyaluronidases. Biotechnol Adv. 2022;60: 108018. https:\/\/doi.org\/10.1016\/j.biotechadv.2022.108018.","journal-title":"Biotechnol Adv"},{"issue":"2","key":"299_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/bj2800309","volume":"280","author":"B Henrissat","year":"1991","unstructured":"Henrissat B. A classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem J. 1991;280(2):309\u201316. https:\/\/doi.org\/10.1042\/bj2800309.","journal-title":"Biochem J"},{"issue":"Pt 2","key":"299_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1042\/bj3160695","volume":"316","author":"B Henrissat","year":"1996","unstructured":"Henrissat B, Bairoch A. Updating the sequence-based classification of glycosyl hydrolases. Biochem J. 1996;316(Pt 2):695\u20136. https:\/\/doi.org\/10.1042\/bj3160695.","journal-title":"Biochem J"},{"issue":"1","key":"299_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/glycob\/cwz069","volume":"30","author":"B Pluvinage","year":"2020","unstructured":"Pluvinage B, Massel PM, Burak K, Boraston AB. Structural and functional analysis of four family 84 glycoside hydrolases from the opportunistic pathogen Clostridium perfringens. Glycobiology. 2020;30(1):58\u201368. https:\/\/doi.org\/10.1093\/glycob\/cwz069.","journal-title":"Glycobiology"},{"issue":"12","key":"299_CR22","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/glycob\/cwq122","volume":"20","author":"M-L Garron","year":"2010","unstructured":"Garron M-L, Cygler M. Structural and mechanistic classification of uronic acid-containing polysaccharide lyases. Glycobiology. 2010;20(12):1547\u201373. https:\/\/doi.org\/10.1093\/glycob\/cwq122.","journal-title":"Glycobiology"},{"key":"299_CR23","doi-asserted-by":"publisher","unstructured":"Weber GC, Buhren BA, Schrumpf H, Wohlrab J, Gerber PA. Clinical applications of hyaluronidase. In: Labrou N, editor. Therapeutic Enzymes: Function and Clinical Implications, vol. 1148, Adv Exp Med Biol. 2019, p. 255\u201377. https:\/\/doi.org\/10.1007\/978-981-13-7709-9_12.","DOI":"10.1007\/978-981-13-7709-9_12"},{"issue":"8","key":"299_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/s0945-053x(01)00170-6","volume":"20","author":"G Lepperdinger","year":"2001","unstructured":"Lepperdinger G, M\u00fcllegger J, Kreil G. Hyal2\u2013less active, but more versatile? Matrix Biol. 2001;20(8):509\u201314. https:\/\/doi.org\/10.1016\/s0945-053x(01)00170-6.","journal-title":"Matrix Biol"},{"key":"299_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fonc.2017.00242","volume":"7","author":"L Bohaumilitzky","year":"2017","unstructured":"Bohaumilitzky L, Huber A-K, Stork EM, Wengert S, Woelfl F, Boehm H. A Trickster in Disguise: Hyaluronan\u2019s Ambivalent Roles in the Matrix. Front Oncol. 2017;7:242. https:\/\/doi.org\/10.3389\/fonc.2017.00242.","journal-title":"Front Oncol"},{"issue":"4","key":"299_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/mrd.1119","volume":"60","author":"CA Vines","year":"2001","unstructured":"Vines CA, Li MW, Deng X, Yudin AI, Cherr GN, Overstreet JW. Identification of a hyaluronic acid (HA) binding domain in the PH-20 protein that may function in cell signaling. Mol Reprod Dev. 2001;60(4):542\u201352. https:\/\/doi.org\/10.1002\/mrd.1119.","journal-title":"Mol Reprod Dev"},{"issue":"8","key":"299_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/s0945-053x(01)00171-8","volume":"20","author":"GN Cherr","year":"2001","unstructured":"Cherr GN, Yudin AI, Overstreet JW. The dual functions of GPI-anchored PH-20: Hyaluronidase and intracellular signaling. Matrix Biol. 2001;20(8):515\u201325. https:\/\/doi.org\/10.1016\/s0945-053x(01)00171-8.","journal-title":"Matrix Biol"},{"issue":"8","key":"299_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.matbio.2008.07.006","volume":"27","author":"V Atmuri","year":"2008","unstructured":"Atmuri V, Martin DC, Hemming R, Gutsol A, Byers S, Sahebjam S, et al. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation. Matrix Biol. 2008;27(8):653\u201360. https:\/\/doi.org\/10.1016\/j.matbio.2008.07.006.","journal-title":"Matrix Biol"},{"issue":"9","key":"299_CR29","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/cncr.26520","volume":"118","author":"A Chi","year":"2012","unstructured":"Chi A, Shirodkar SP, Escudero DO, Ekwenna OO, Yates TJ, Ayyathurai R, et al. Molecular characterization of kidney cancer: Association of hyaluronic acid family with histological subtypes and metastasis. Cancer. 2012;118(9):2394\u2013402. https:\/\/doi.org\/10.1002\/cncr.26520.","journal-title":"Cancer"},{"issue":"14","key":"299_CR30","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1073\/pnas.1215432110","volume":"110","author":"H Yoshida","year":"2013","unstructured":"Yoshida H, Nagaoka A, Kusaka-Kikushima A, Tobiishi M, Kawabata K, Sayo T, et al. KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. Proc Natl Acad Sci U S A. 2013;110(14):5612\u20137. https:\/\/doi.org\/10.1073\/pnas.1215432110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"299_CR31","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1074\/jbc.M116.770149","volume":"292","author":"H Yamamoto","year":"2017","unstructured":"Yamamoto H, Tobisawa Y, Inubushi T, Irie F, Ohyama C, Yamaguchi Y. A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase. J Biol Chem. 2017;292(18):7304\u201313. https:\/\/doi.org\/10.1074\/jbc.M116.770149.","journal-title":"J Biol Chem"},{"key":"299_CR32","doi-asserted-by":"publisher","unstructured":"Niu M, McGrath M, Sammon D, Gardner S, Morgan RM, Di Maio A, et al. Structure of the transmembrane protein 2 (TMEM2) ectodomain and its apparent lack of hyaluronidase activity. Wellcome Open Res. 2023;8:76. https:\/\/doi.org\/10.12688\/wellcomeopenres.18937.2.","DOI":"10.12688\/wellcomeopenres.18937.2"},{"issue":"6","key":"299_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104826","volume":"299","author":"S Sato","year":"2023","unstructured":"Sato S, Miyazaki M, Fukuda S, Mizutani Y, Mizukami Y, Higashiyama S, et al. Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199\/CEMIP) and HAS2 expression. J Biol Chem. 2023;299(6): 104826. https:\/\/doi.org\/10.1016\/j.jbc.2023.104826.","journal-title":"J Biol Chem"},{"issue":"9","key":"299_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105120","volume":"299","author":"T Narita","year":"2023","unstructured":"Narita T, Tobisawa Y, Bobkov A, Jackson M, Ohyama C, Irie F, et al. TMEM2 is a bona fide hyaluronidase possessing intrinsic catalytic activity. J Biol Chem. 2023;299(9): 105120. https:\/\/doi.org\/10.1016\/j.jbc.2023.105120.","journal-title":"J Biol Chem"},{"issue":"50","key":"299_CR35","doi-asserted-by":"publisher","first-page":"18028","DOI":"10.1073\/pnas.0506825102","volume":"102","author":"E Kim","year":"2005","unstructured":"Kim E, Baba D, Kimura M, Yamashita M, Kashiwabara S, Baba T. Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. Proc Natl Acad Sci U S A. 2005;102(50):18028\u201333. https:\/\/doi.org\/10.1073\/pnas.0506825102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"299_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/BJ20060598","volume":"401","author":"S Reitinger","year":"2007","unstructured":"Reitinger S, Laschober GT, Fehrer C, Greiderer B, Lepperdinger G. Mouse testicular hyaluronidase-like proteins SPAM1 and HYAL5 but not HYALP1 degrade hyaluronan. Biochem J. 2007;401(1):79\u201385. https:\/\/doi.org\/10.1042\/BJ20060598.","journal-title":"Biochem J"},{"issue":"5","key":"299_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1095\/biolreprod.109.078816","volume":"81","author":"M Kimura","year":"2009","unstructured":"Kimura M, Kim E, Kang W, Yamashita M, Saigo M, Yamazaki T, et al. Functional Roles of Mouse Sperm Hyaluronidases, HYAL5 and SPAM1, in Fertilization1. Biol Reprod. 2009;81(5):939\u201347. https:\/\/doi.org\/10.1095\/biolreprod.109.078816.","journal-title":"Biol Reprod"},{"issue":"12","key":"299_CR38","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1096\/fj.201900889RRR","volume":"33","author":"S Park","year":"2019","unstructured":"Park S, Kim Y, Jeong P, Park C, Lee J, Kim J, et al. SPAM1\/HYAL5 double deficiency in male mice leads to severe male subfertility caused by a cumulus-oocyte complex penetration defect. FASEB J. 2019;33(12):14440\u20139. https:\/\/doi.org\/10.1096\/fj.201900889RRR.","journal-title":"FASEB J"},{"key":"299_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2024.124031","volume":"1234","author":"SM Modarressi","year":"2024","unstructured":"Modarressi SM, Koolivand Z, Akbari M. Enhancing hyaluronidase enzyme activity: Insights from advancement in bovine and ovine testicular hyaluronidase purification. Chromatogr B Analyt Technol Biomed Life Sci. 2024;1234: 124031. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124031.","journal-title":"Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"299_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/prot.20592","volume":"61","author":"MJ Jedrzejas","year":"2005","unstructured":"Jedrzejas MJ, Stern R. Structures of vertebrate hyaluronidases and their unique enzymatic mechanism of hydrolysis. Proteins. 2005;61(2):227\u201338. https:\/\/doi.org\/10.1002\/prot.20592.","journal-title":"Proteins"},{"issue":"7","key":"299_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/0929866525666180629121823","volume":"25","author":"N Khan","year":"2018","unstructured":"Khan N, Niazi ZR, Rehman FU, Akhtar A, Khan MM, Khan S, et al. Hyaluronidases: A Therapeutic Enzyme. Protein Pept Lett. 2018;25(7):663\u201376. https:\/\/doi.org\/10.2174\/0929866525666180629121823.","journal-title":"Protein Pept Lett"},{"key":"299_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jprot.2018.08.012","volume":"192","author":"T Barth","year":"2019","unstructured":"Barth T, Mandacaru SC, Charneau S, Souza MVD, Ricart CAO, Noronha EF, et al. Biochemical and structural characterization of a protein complex containing a hyaluronidase and a CRISP-like protein isolated from the venom of the spider Acanthoscurria natalensis. J Proteomics. 2019;192:102\u201313. https:\/\/doi.org\/10.1016\/j.jprot.2018.08.012.","journal-title":"J Proteomics"},{"issue":"4","key":"299_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/toxins11040191","volume":"11","author":"J Frangieh","year":"2019","unstructured":"Frangieh J, Salma Y, Haddad K, Mattei C, Legros C, Fajloun Z, et al. First Characterization of The Venom from Apis mellifera syriaca, A Honeybee from The Middle East Region. Toxins. 2019;11(4):191. https:\/\/doi.org\/10.3390\/toxins11040191.","journal-title":"Toxins"},{"issue":"5","key":"299_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002206","volume":"7","author":"VP Ferrer","year":"2013","unstructured":"Ferrer VP, De Mari TL, Gremski LH, Trevisan Silva D, Da Silveira RB, Gremski W, et al. A Novel Hyaluronidase from Brown Spider (Loxosceles intermedia) Venom (Dietrich\u2019s Hyaluronidase): From Cloning to Functional Characterization. PLoS Negl Trop Dis. 2013;7(5): e2206. https:\/\/doi.org\/10.1371\/journal.pntd.0002206.","journal-title":"PLoS Negl Trop Dis"},{"key":"299_CR45","doi-asserted-by":"publisher","unstructured":"Justo Jacomini DL, Campos Pereira FD, Aparecido Dos Santos Pinto JR, Dos Santos LD, Da Silva Neto AJ, Giratto DT, et al. Hyaluronidase from the venom of the social wasp Polybia paulista (Hymenoptera, Vespidae): Cloning, structural modeling, purification, and immunological analysis. Toxicon. 2013;64:70\u201380. https:\/\/doi.org\/10.1016\/j.toxicon.2012.12.019.","DOI":"10.1016\/j.toxicon.2012.12.019"},{"key":"299_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.aller.2017.05.003","volume":"46","author":"D Antol\u00edn-Am\u00e9rigo","year":"2018","unstructured":"Antol\u00edn-Am\u00e9rigo D, Ruiz-Le\u00f3n B, Boni E, Alfaya-Arias T, \u00c1lvarez-Mon M, Barbarroja-Escudero J, et al. Component-resolved diagnosis in hymenoptera allergy. Allergol Immunopathol (Madr). 2018;46:253\u201362. https:\/\/doi.org\/10.1016\/j.aller.2017.05.003.","journal-title":"Allergol Immunopathol (Madr)"},{"key":"299_CR47","doi-asserted-by":"publisher","unstructured":"Ru\u00ebff F, Bauer A, Becker S, Brehler R, Brockow K, Chaker AM, et al. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft f\u00fcr Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (\u00d6GAI). Allergol Select. 2023;7:154\u201390. https:\/\/doi.org\/10.5414\/ALX02430E.","DOI":"10.5414\/ALX02430E"},{"issue":"9","key":"299_CR48","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1080\/07391102.2016.1203820","volume":"35","author":"V Sivaramakrishnan","year":"2017","unstructured":"Sivaramakrishnan V, Ilamathi M, Girish KS, Kemparaju K, Rangappa KS, Dhananjaya BL. Viper venom hyaluronidase and its potential inhibitor analysis: a multipronged computational investigation. J Biomol Struct Dyn. 2017;35(9):1979\u201389. https:\/\/doi.org\/10.1080\/07391102.2016.1203820.","journal-title":"J Biomol Struct Dyn"},{"key":"299_CR49","doi-asserted-by":"publisher","unstructured":"Silva De Fran\u00e7a F, Tambourgi DV. Hyaluronan breakdown by snake venom hyaluronidases: From toxins delivery to immunopathology. Front Immunol. 2023;14:1125899. https:\/\/doi.org\/10.3389\/fimmu.2023.1125899.","DOI":"10.3389\/fimmu.2023.1125899"},{"issue":"3","key":"299_CR50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1084\/jem.66.3.353","volume":"66","author":"A Claude","year":"1937","unstructured":"Claude A. SPREADING PROPERTIES OF LEECH EXTRACTS AND THE FORMATION OF LYMPH. J Exp Med. 1937;66(3):353\u201366. https:\/\/doi.org\/10.1084\/jem.66.3.353.","journal-title":"J Exp Med"},{"issue":"2","key":"299_CR51","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00253-015-7056-5","volume":"100","author":"Z Kang","year":"2016","unstructured":"Kang Z, Zhang N, Zhang Y. Enhanced production of leech hyaluronidase by optimizing secretion and cultivation in Pichia pastoris. Appl Microbiol Biotechnol. 2016;100(2):707\u201317. https:\/\/doi.org\/10.1007\/s00253-015-7056-5.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"299_CR52","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00253-019-10282-7","volume":"104","author":"H Huang","year":"2020","unstructured":"Huang H, Liang Q, Wang Y, Chen J, Kang Z. High-level constitutive expression of leech hyaluronidase with combined strategies in recombinant Pichia pastoris. Appl Microbiol Biotechnol. 2020;104(4):1621\u201332. https:\/\/doi.org\/10.1007\/s00253-019-10282-7.","journal-title":"Appl Microbiol Biotechnol"},{"key":"299_CR53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.carbpol.2016.01.052","volume":"142","author":"M Lv","year":"2016","unstructured":"Lv M, Wang M, Cai W, Hao W, Yuan P, Kang Z. Characterisation of separated end hyaluronan oligosaccharides from leech hyaluronidase and evaluation of angiogenesis. Carbohydr Polym. 2016;142:309\u201316. https:\/\/doi.org\/10.1016\/j.carbpol.2016.01.052.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"299_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40643-024-00832-x","volume":"11","author":"J-Y Jiang","year":"2024","unstructured":"Jiang J-Y, Xue D, Gong J-S, Zheng Q-X, Zhang Y-S, Su C, et al. A comprehensive review on microbial hyaluronan-degrading enzymes: from virulence factors to biotechnological tools. Bioresour Bioprocess. 2024;11(1):114. https:\/\/doi.org\/10.1186\/s40643-024-00832-x.","journal-title":"Bioresour Bioprocess"},{"key":"299_CR55","doi-asserted-by":"publisher","unstructured":"Coleman M, Orvis A, Brokaw A, Furuta A, Sharma K, Quach P, et al. GBS hyaluronidase mediates immune suppression in a TLR2\/4- and IL-10-dependent manner during pregnancy-associated infection. mBio. 2023; 14(5):e02049\u201323. https:\/\/doi.org\/10.1128\/mbio.02049-23.","DOI":"10.1128\/mbio.02049-23"},{"issue":"1","key":"299_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.celrep.2019.12.001","volume":"30","author":"T Dokoshi","year":"2020","unstructured":"Dokoshi T, Zhang L, Li F, Nakatsuji T, Butcher A, Yoshida H, et al. Hyaluronan Degradation by Cemip Regulates Host Defense against Staphylococcus aureus Skin Infection. Cell Rep. 2020;30(1):61-68.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.001.","journal-title":"Cell Rep"},{"key":"299_CR57","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.bioactmat.2022.04.023","volume":"19","author":"F Zamboni","year":"2023","unstructured":"Zamboni F, Wong CK, Collins MN. Hyaluronic acid association with bacterial, fungal and viral infections: Can hyaluronic acid be used as an antimicrobial polymer for biomedical and pharmaceutical applications? Bioact Mater. 2023;19:458\u201373. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.04.023.","journal-title":"Bioact Mater"},{"issue":"2","key":"299_CR58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.chom.2021.12.006","volume":"30","author":"J Feng","year":"2022","unstructured":"Feng J, Qian Y, Zhou Z, Ertmer S, Vivas EI, Lan F, et al. Polysaccharide utilization loci in Bacteroides determine population fitness and community-level interactions. Cell Host Microbe. 2022;30(2):200-215.e12. https:\/\/doi.org\/10.1016\/j.chom.2021.12.006.","journal-title":"Cell Host Microbe"},{"key":"299_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtla.2023.101826","volume":"30","author":"N Osman","year":"2023","unstructured":"Osman N, Mohammed M, Omolo CA, Ibrahim UH, Gafar MA, Rambharose S, et al. Hyaluronidase inhibitor surface-modified niosomes: An efficient strategy for antibacterial and anti-biofilm drug delivery. Materialia. 2023;30: 101826. https:\/\/doi.org\/10.1016\/j.mtla.2023.101826.","journal-title":"Materialia"},{"issue":"6","key":"299_CR60","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1128\/IAI.00022-14","volume":"82","author":"Z Wang","year":"2014","unstructured":"Wang Z, Guo C, Xu Y, Liu G, Lu C, Liu Y. Two Novel Functions of Hyaluronidase from Streptococcus agalactiae Are Enhanced Intracellular Survival and Inhibition of Proinflammatory Cytokine Expression. Infect Immun. 2014;82(6):2615\u201325. https:\/\/doi.org\/10.1128\/IAI.00022-14.","journal-title":"Infect Immun"},{"issue":"1","key":"299_CR61","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1038\/s41467-023-43833-8","volume":"14","author":"IA Hajam","year":"2023","unstructured":"Hajam IA, Katiki M, McNally R, L\u00e1zaro-D\u00edez M, Kolar S, Chatterjee A, et al. Functional divergence of a bacterial enzyme promotes healthy or acneic skin. Nat Commun. 2023;14(1):8061. https:\/\/doi.org\/10.1038\/s41467-023-43833-8.","journal-title":"Nat Commun"},{"issue":"1","key":"299_CR62","doi-asserted-by":"publisher","first-page":"1972757","DOI":"10.1080\/19490976.2021.1972757","volume":"13","author":"T Mao","year":"2021","unstructured":"Mao T, Su C-W, Ji Q, Chen C-Y, Wang R, Vijaya Kumar D, et al. Hyaluronan-induced alterations of the gut microbiome protects mice against Citrobacter rodentium infection and intestinal inflammation. Gut Microbes. 2021;13(1):1972757. https:\/\/doi.org\/10.1080\/19490976.2021.1972757.","journal-title":"Gut Microbes"},{"issue":"9","key":"299_CR63","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3390\/polym15092103","volume":"15","author":"R Zhao","year":"2023","unstructured":"Zhao R, Zhang C, Yu L, Zhang C, Zhao J, Narbad A, et al. In Vitro Fermentation of Hyaluronan with Different Molecular Weights by Human Gut Microbiota: Differential Effects on Gut Microbiota Structure and Metabolic Function. Polymers. 2023;15(9):2103. https:\/\/doi.org\/10.3390\/polym15092103.","journal-title":"Polymers"},{"issue":"1","key":"299_CR64","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41467-020-14509-4","volume":"11","author":"D Ndeh","year":"2020","unstructured":"Ndeh D, Basl\u00e9 A, Strahl H, Yates EA, McClurgg UL, Henrissat B, et al. Metabolism of multiple glycosaminoglycans by Bacteroides thetaiotaomicron is orchestrated by a versatile core genetic locus. Nat Commun. 2020;11(1):646. https:\/\/doi.org\/10.1038\/s41467-020-14509-4.","journal-title":"Nat Commun"},{"key":"299_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118313","volume":"269","author":"L Pan","year":"2021","unstructured":"Pan L, Ai X, Fu T, Ren L, Shang Q, Li G, et al. In vitro fermentation of hyaluronan by human gut microbiota: Changes in microbiota community and potential degradation mechanism. Carbohydr Polym. 2021;269: 118313. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118313.","journal-title":"Carbohydr Polym"},{"key":"299_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.120153","volume":"299","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wang B, Tang X, Mao B, Zhang Q, Zhang T, et al. Absorption, metabolism, and functions of hyaluronic acid and its therapeutic prospects in combination with microorganisms: A review. Carbohydr Polym. 2023;299: 120153. https:\/\/doi.org\/10.1016\/j.carbpol.2022.120153.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"299_CR67","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.canlet.2010.07.011","volume":"298","author":"JH Lee","year":"2010","unstructured":"Lee JH, Moore LD, Kumar S, Pritchard DG, Ponnazhagan S, Deivanayagam C. Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronan-mediated Erk1\/2 activation and RhoA expression in human breast carcinoma cells. Cancer Lett. 2010;298(2):238\u201349. https:\/\/doi.org\/10.1016\/j.canlet.2010.07.011.","journal-title":"Cancer Lett"},{"issue":"4","key":"299_CR68","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/jmse11040778","volume":"11","author":"K Thirumurthy","year":"2023","unstructured":"Thirumurthy K, Kaliyamoorthy K, Kandasamy K, Ponnuvel M, Viyakarn V, Chavanich S, et al. Antioxidant and Anti-Breast Cancer Properties of Hyaluronidase from Marine Staphylococcus aureus (CASMTK1). JMSE. 2023;11(4):778. https:\/\/doi.org\/10.3390\/jmse11040778.","journal-title":"JMSE"},{"issue":"2","key":"299_CR69","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/1535-7163.MCT-19-0556","volume":"19","author":"ND Ebelt","year":"2020","unstructured":"Ebelt ND, Zuniga E, Passi KB, Sobocinski LJ, Manuel ER. Hyaluronidase-Expressing Salmonella Effectively Targets Tumor-Associated Hyaluronic Acid in Pancreatic Ductal Adenocarcinoma. Mol Cancer Ther. 2020;19(2):706\u201316. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0556.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"299_CR70","doi-asserted-by":"publisher","first-page":"2101487","DOI":"10.1002\/adhm.202101487","volume":"11","author":"SC Thomas","year":"2022","unstructured":"Thomas SC, Madaan T, Kamble NS, Siddiqui NA, Pauletti GM, Kotagiri N. Engineered Bacteria Enhance Immunotherapy and Targeted Therapy through Stromal Remodeling of Tumors. Adv Healthc Mater. 2022;11(2):2101487. https:\/\/doi.org\/10.1002\/adhm.202101487.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"299_CR71","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/s0969-2126(00)00511-6","volume":"8","author":"Z Markovi\u0107-Housley","year":"2000","unstructured":"Markovi\u0107-Housley Z, Miglierini G, Soldatova L, Rizkallah PJ, M\u00fcller U, Schirmer T. Crystal structure of hyaluronidase, a major allergen of bee venom. Structure. 2000;8(10):1025\u201335. https:\/\/doi.org\/10.1016\/s0969-2126(00)00511-6.","journal-title":"Structure"},{"issue":"44","key":"299_CR72","doi-asserted-by":"publisher","first-page":"15973","DOI":"10.1074\/jbc.RA119.010619","volume":"294","author":"AH Viborg","year":"2019","unstructured":"Viborg AH, Terrapon N, Lombard V, Michel G, Czjzek M, Henrissat B, et al. A subfamily roadmap of the evolutionarily diverse glycoside hydrolase family 16 (GH16). J Biol Chem. 2019;294(44):15973\u201386. https:\/\/doi.org\/10.1074\/jbc.RA119.010619.","journal-title":"J Biol Chem"},{"key":"299_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100385","volume":"296","author":"MV Liberato","year":"2021","unstructured":"Liberato MV, Teixeira Prates E, Gon\u00e7alves TA, Bernardes A, Vilela N, Fattori J, et al. Insights into the dual cleavage activity of the GH16 laminarinase enzyme class on \u03b2-1,3 and \u03b2-1,4 glycosidic bonds. J Biol Chem. 2021;296: 100385. https:\/\/doi.org\/10.1016\/j.jbc.2021.100385.","journal-title":"J Biol Chem"},{"key":"299_CR74","doi-asserted-by":"publisher","unstructured":"Skov LK, Sepp\u00e4l\u00e4 U, Coen JJF, Crickmore N, King TP, Monsalve R, et al. Structure of recombinant Ves v 2 at 2.0 Angstrom resolution: structural analysis of an allergenic hyaluronidase from wasp venom. Acta Crystallogr D Biol Crystallogr. 2006;62(Pt 6):595\u2013604. https:\/\/doi.org\/10.1107\/S0907444906010687.","DOI":"10.1107\/S0907444906010687"},{"issue":"11","key":"299_CR75","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1021\/bi052370b","volume":"45","author":"N \u00c7etinba\u015f","year":"2006","unstructured":"\u00c7etinba\u015f N, Macauley MS, Stubbs KA, Drapala R, Vocadlo DJ. Identification of Asp174 and Asp175 as the Key Catalytic Residues of Human O -GlcNAcase by Functional Analysis of Site-Directed Mutants. Biochemistry. 2006;45(11):3835\u201344. https:\/\/doi.org\/10.1021\/bi052370b.","journal-title":"Biochemistry"},{"key":"299_CR76","doi-asserted-by":"publisher","unstructured":"Calvelo M, Males A, Alteen MG, Willems LI, Vocadlo DJ, Davies GJ, et al. Human O-GlcNAcase Uses a Preactivated Boat-skew Substrate Conformation for Catalysis. Evidence from X-ray Crystallography and QM\/MM Metadynamics. ACS Catal. 2023; 13(20):13672\u20138. https:\/\/doi.org\/10.1021\/acscatal.3c02378.","DOI":"10.1021\/acscatal.3c02378"},{"issue":"17","key":"299_CR77","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1074\/jbc.M112.346288","volume":"287","author":"M Michikawa","year":"2012","unstructured":"Michikawa M, Ichinose H, Momma M, Biely P, Jongkees S, Yoshida M, et al. Structural and Biochemical Characterization of Glycoside Hydrolase Family 79 \u03b2-Glucuronidase from Acidobacterium capsulatum. J Biol Chem. 2012;287(17):14069\u201377. https:\/\/doi.org\/10.1074\/jbc.M112.346288.","journal-title":"J Biol Chem"},{"key":"299_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118838","volume":"277","author":"H Huang","year":"2022","unstructured":"Huang H, Hou X, Xu R, Deng Z, Wang Y, Du G, et al. Structure and cleavage pattern of a hyaluronate 3-glycanohydrolase in the glycoside hydrolase 79 family. Carbohydr Polym. 2022;277: 118838. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118838.","journal-title":"Carbohydr Polym"},{"issue":"4","key":"299_CR79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/glycob\/11.4.297","volume":"11","author":"SJ Kelly","year":"2001","unstructured":"Kelly SJ, Taylor KB, Li S, Jedrzejas MJ. Kinetic properties of Streptococcus pneumoniae hyaluronate lyase. Glycobiology. 2001;11(4):297\u2013304. https:\/\/doi.org\/10.1093\/glycob\/11.4.297.","journal-title":"Glycobiology"},{"key":"299_CR80","doi-asserted-by":"publisher","unstructured":"Ponnuraj K, Jedrzejas MJ. Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution. J Mol Biol. 2000; 299(4):885\u201395. https:\/\/doi.org\/10.1006\/jmbi.2000.3817.","DOI":"10.1006\/jmbi.2000.3817"},{"issue":"14","key":"299_CR81","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/1873-3468.12258","volume":"590","author":"L Messina","year":"2016","unstructured":"Messina L, Gavira JA, Pernagallo S, Unciti-Broceta JD, Sanchez Martin RM, Diaz-Mochon JJ, et al. Identification and characterization of a bacterial hyaluronidase and its production in recombinant form. FEBS Lett. 2016;590(14):2180\u20139. https:\/\/doi.org\/10.1002\/1873-3468.12258.","journal-title":"FEBS Lett"},{"issue":"13","key":"299_CR82","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1073\/pnas.1815791116","volume":"116","author":"W Helbert","year":"2019","unstructured":"Helbert W, Poulet L, Drouillard S, Mathieu S, Loiodice M, Couturier M, et al. Discovery of novel carbohydrate-active enzymes through the rational exploration of the protein sequences space. Proc Natl Acad Sci U S A. 2019;116(13):6063\u20138. https:\/\/doi.org\/10.1073\/pnas.1815791116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"299_CR83","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.febslet.2010.11.021","volume":"585","author":"M Bakke","year":"2011","unstructured":"Bakke M, Kamei J, Obata A. Identification, characterization, and molecular cloning of a novel hyaluronidase, a member of glycosyl hydrolase family 16, from Penicillium spp. FEBS Lett. 2011;585(1):115\u201320. https:\/\/doi.org\/10.1016\/j.febslet.2010.11.021.","journal-title":"FEBS Lett"},{"key":"299_CR84","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9199-JVATITD-2019-0030","volume":"25","author":"P Rungsa","year":"2019","unstructured":"Rungsa P, Janpan P, Saengkun Y, Jangpromma N, Klaynongsruang S, Patramanon R, et al. Heterologous expression and mutagenesis of recombinant Vespa affinis hyaluronidase protein (rVesA2). J Venom Anim Toxins Incl Trop Dis. 2019;25: e20190030. https:\/\/doi.org\/10.1590\/1678-9199-JVATITD-2019-0030.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"1","key":"299_CR85","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00253-017-8624-7","volume":"102","author":"R Zhang","year":"2018","unstructured":"Zhang R, Zhou J, Song Z, Huang Z. Enzymatic properties of \u03b2-N-acetylglucosaminidases. Appl Microbiol Biotechnol. 2018;102(1):93\u2013103. https:\/\/doi.org\/10.1007\/s00253-017-8624-7.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"299_CR86","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0167-4838(00)00231-4","volume":"1543","author":"A Planas","year":"2000","unstructured":"Planas A. Bacterial 1,3\u20131,4-beta-glucanases: structure, function and protein engineering. Biochim Biophys Acta. 2000;1543(2):361\u201382. https:\/\/doi.org\/10.1016\/s0167-4838(00)00231-4.","journal-title":"Biochim Biophys Acta"},{"key":"299_CR87","doi-asserted-by":"publisher","unstructured":"Jedrzejas MJ, Mello LV, de Groot BL, Li S. Mechanism of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. Structures of complexes with the substrate. J Biol Chem. 2002; 277(31):28287\u201397. https:\/\/doi.org\/10.1074\/jbc.M112009200.","DOI":"10.1074\/jbc.M112009200"},{"issue":"6","key":"299_CR88","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/emboj\/19.6.1228","volume":"19","author":"S Li","year":"2000","unstructured":"Li S, Kelly SJ, Lamani E, Ferraroni M, Jedrzejas MJ. Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. EMBO J. 2000;19(6):1228\u201340. https:\/\/doi.org\/10.1093\/emboj\/19.6.1228.","journal-title":"EMBO J"},{"key":"299_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107993","volume":"232","author":"S Garantziotis","year":"2022","unstructured":"Garantziotis S. Modulation of hyaluronan signaling as a therapeutic target in human disease. Pharmacol Ther. 2022;232: 107993. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107993.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"299_CR90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s43094-024-00636-y","volume":"10","author":"ARC Salih","year":"2024","unstructured":"Salih ARC, Farooqi HMU, Amin H, Karn PR, Meghani N, Nagendran S. Hyaluronic acid: comprehensive review of a multifunctional biopolymer. Futur J Pharm Sci. 2024;10(1):63. https:\/\/doi.org\/10.1186\/s43094-024-00636-y.","journal-title":"Futur J Pharm Sci"},{"issue":"13","key":"299_CR91","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.carres.2009.06.001","volume":"344","author":"C Martinez-Fleites","year":"2009","unstructured":"Martinez-Fleites C, Korczynska JE, Davies GJ, Cope MJ, Turkenburg JP, Taylor EJ. The crystal structure of a family GH25 lysozyme from Bacillus anthracis implies a neighboring-group catalytic mechanism with retention of anomeric configuration. Carbohydr Res. 2009;344(13):1753\u20137. https:\/\/doi.org\/10.1016\/j.carres.2009.06.001.","journal-title":"Carbohydr Res"},{"issue":"2","key":"299_CR92","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.carbpol.2010.02.047","volume":"81","author":"NS El-Safory","year":"2010","unstructured":"El-Safory NS, Fazary AE, Lee C-K. Hyaluronidases, a group of glycosidases: Current and future perspectives. Carbohydr Polym. 2010;81(2):165\u201381. https:\/\/doi.org\/10.1016\/j.carbpol.2010.02.047.","journal-title":"Carbohydr Polym"},{"issue":"7","key":"299_CR93","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/j.1742-4658.2010.07600.x","volume":"277","author":"I Kakizaki","year":"2010","unstructured":"Kakizaki I, Ibori N, Kojima K, Yamaguchi M, Endo M. Mechanism for the hydrolysis of hyaluronan oligosaccharides by bovine testicular hyaluronidase. FEBS J. 2010;277(7):1776\u201386. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07600.x.","journal-title":"FEBS J"},{"key":"299_CR94","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ijbiomac.2021.07.098","volume":"187","author":"M Amin","year":"2021","unstructured":"Amin M, Barzegari E, Pourshohod A, Zeinali M, Jamalan M. 3D structure prediction, dynamic investigation and rational construction of an epitope-masked thermostable bovine hyaluronidase. Int J Biol Macromol. 2021;187:544\u201353. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.07.098.","journal-title":"Int J Biol Macromol"},{"issue":"23","key":"299_CR95","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1021\/bi700382g","volume":"46","author":"KL Chao","year":"2007","unstructured":"Chao KL, Muthukumar L, Herzberg O. Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. Biochemistry. 2007;46(23):6911\u201320. https:\/\/doi.org\/10.1021\/bi700382g.","journal-title":"Biochemistry"},{"key":"299_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.926353","volume":"10","author":"F Yuan","year":"2022","unstructured":"Yuan F, Yang Y, Zhou H, Quan J, Liu C, Wang Y, et al. Heparanase in cancer progression: Structure, substrate recognition and therapeutic potential. Front Chem. 2022;10: 926353. https:\/\/doi.org\/10.3389\/fchem.2022.926353.","journal-title":"Front Chem"},{"issue":"9","key":"299_CR97","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0969-2126(01)00220-9","volume":"3","author":"G Davies","year":"1995","unstructured":"Davies G, Henrissat B. Structures and mechanisms of glycosyl hydrolases. Structure. 1995;3(9):853\u20139. https:\/\/doi.org\/10.1016\/S0969-2126(01)00220-9.","journal-title":"Structure"},{"issue":"1","key":"299_CR98","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/s42003-022-04141-x","volume":"5","author":"C Schmerling","year":"2022","unstructured":"Schmerling C, Sewald L, Heilmann G, Witfeld F, Begerow D, Jensen K, et al. Identification of fungal lignocellulose-degrading biocatalysts secreted by Phanerochaete chrysosporium via activity-based protein profiling. Commun Biol. 2022;5(1):1254. https:\/\/doi.org\/10.1038\/s42003-022-04141-x.","journal-title":"Commun Biol"},{"issue":"2","key":"299_CR99","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/bit.22838","volume":"107","author":"TV Vuong","year":"2010","unstructured":"Vuong TV, Wilson DB. Glycoside hydrolases: Catalytic base\/nucleophile diversity. Biotechnol Bioeng. 2010;107(2):195\u2013205. https:\/\/doi.org\/10.1002\/bit.22838.","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"299_CR100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/jof7020080","volume":"7","author":"B Pilgaard","year":"2021","unstructured":"Pilgaard B, Vuillemin M, Holck J, Wilkens C, Meyer AS. Specificities and Synergistic Actions of Novel PL8 and PL7 Alginate Lyases from the Marine Fungus Paradendryphiella salina. J Fungi (Basel). 2021;7(2):80. https:\/\/doi.org\/10.3390\/jof7020080.","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"299_CR101","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/prot.22938","volume":"79","author":"ZH Elmabrouk","year":"2011","unstructured":"Elmabrouk ZH, Vincent F, Zhang M, Smith NL, Turkenburg JP, Charnock SJ, et al. Crystal structures of a family 8 polysaccharide lyase reveal open and highly occluded substrate-binding cleft conformations. Proteins. 2011;79(3):965\u201374. https:\/\/doi.org\/10.1002\/prot.22938.","journal-title":"Proteins"},{"issue":"3","key":"299_CR102","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s12010-015-1774-0","volume":"177","author":"D Smirnou","year":"2015","unstructured":"Smirnou D, Kr\u010dm\u00e1\u0159 M, Kulh\u00e1nek J, Hermannov\u00e1 M, Bobkov\u00e1 L, Franke L, et al. Characterization of Hyaluronan-Degrading Enzymes from Yeasts. Appl Biochem Biotechnol. 2015;177(3):700\u201312. https:\/\/doi.org\/10.1007\/s12010-015-1774-0.","journal-title":"Appl Biochem Biotechnol"},{"issue":"10","key":"299_CR103","doi-asserted-by":"publisher","first-page":"6782","DOI":"10.1007\/s12010-024-04883-w","volume":"196","author":"L Zhu","year":"2024","unstructured":"Zhu L, Li S, Jiang J-Y, Yao Z-Y, Li Q, Lian S-J, et al. High-Level Extracellular Expression of Hyaluronate Lyase HylP in Bacillus subtilis for Hyaluronan Degradation. Appl Biochem Biotechnol. 2024;196(10):6782\u2013801. https:\/\/doi.org\/10.1007\/s12010-024-04883-w.","journal-title":"Appl Biochem Biotechnol"},{"issue":"1","key":"299_CR104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0003-9861(02)00724-5","volume":"411","author":"S Al-Assaf","year":"2003","unstructured":"Al-Assaf S, Navaratnam S, Parsons BJ, Phillips GO. Chain scission of hyaluronan by peroxynitrite. Arch Biochem Biophys. 2003;411(1):73\u201382. https:\/\/doi.org\/10.1016\/s0003-9861(02)00724-5.","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"299_CR105","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.freeradbiomed.2006.01.033","volume":"40","author":"S Al-Assaf","year":"2006","unstructured":"Al-Assaf S, Navaratnam S, Parsons BJ, Phillips GO. Chain scission of hyaluronan by carbonate and dichloride radical anions: potential reactive oxidative species in inflammation? Free Radic Biol Med. 2006;40(11):2018\u201327. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2006.01.033.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"299_CR106","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3109\/10715762.2014.985220","volume":"49","author":"BJ Parsons","year":"2015","unstructured":"Parsons BJ. Oxidation of glycosaminoglycans by free radicals and reactive oxidative species: A review of investigative methods. Free Radic Res. 2015;49(5):618\u201332. https:\/\/doi.org\/10.3109\/10715762.2014.985220.","journal-title":"Free Radic Res"},{"key":"299_CR107","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.freeradbiomed.2013.05.012","volume":"63","author":"S Sibanda","year":"2013","unstructured":"Sibanda S, Parsons BJ, Houee-Levin C, Marignier J-L, Paterson AWJ, Heyes DJ. One-electron oxidation and reduction of glycosaminoglycan chloramides: A kinetic study. Free Radic Biol Med. 2013;63:126\u201334. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.05.012.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"299_CR108","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0945-053x(01)00184-6","volume":"21","author":"PW Noble","year":"2002","unstructured":"Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002;21(1):25\u20139. https:\/\/doi.org\/10.1016\/s0945-053x(01)00184-6.","journal-title":"Matrix Biol"},{"key":"299_CR109","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2018.04.012","volume":"78\u201379","author":"MI Tammi","year":"2019","unstructured":"Tammi MI, Oikari S, Pasonen-Sepp\u00e4nen S, Rilla K, Auvinen P, Tammi RH. Activated hyaluronan metabolism in the tumor matrix - Causes and consequences. Matrix Biol. 2019;78\u201379:147\u201364. https:\/\/doi.org\/10.1016\/j.matbio.2018.04.012.","journal-title":"Matrix Biol"},{"key":"299_CR110","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.abb.2019.01.015","volume":"663","author":"A Avenoso","year":"2019","unstructured":"Avenoso A, Bruschetta G, D\u2019Ascola A, Scuruchi M, Mandraffino G, Gullace R, et al. Hyaluronan fragments produced during tissue injury: A signal amplifying the inflammatory response. Arch Biochem Biophys. 2019;663:228\u201338. https:\/\/doi.org\/10.1016\/j.abb.2019.01.015.","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"299_CR111","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1016\/j.actbio.2013.03.005","volume":"9","author":"A Fakhari","year":"2013","unstructured":"Fakhari A, Berkland C. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment. Acta Biomater. 2013;9(7):7081\u201392. https:\/\/doi.org\/10.1016\/j.actbio.2013.03.005.","journal-title":"Acta Biomater"},{"issue":"3","key":"299_CR112","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4331\/wjbc.v6.i3.110","volume":"6","author":"B Triggs-Raine","year":"2015","unstructured":"Triggs-Raine B, Natowicz MR. Biology of hyaluronan: Insights from genetic disorders of hyaluronan metabolism. World J Biol Chem. 2015;6(3):110\u201320. https:\/\/doi.org\/10.4331\/wjbc.v6.i3.110.","journal-title":"World J Biol Chem"},{"issue":"5","key":"299_CR113","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/s1734-1140(13)71465-8","volume":"65","author":"MS Karbownik","year":"2013","unstructured":"Karbownik MS, Nowak JZ. Hyaluronan: towards novel anti-cancer therapeutics. Pharmacol Rep. 2013;65(5):1056\u201374. https:\/\/doi.org\/10.1016\/s1734-1140(13)71465-8.","journal-title":"Pharmacol Rep"},{"key":"299_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.696096","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Wei Z, Wu H, Li Y, Han F, Yu W. Characterization of a Hyaluronic Acid Utilization Locus and Identification of Two Hyaluronate Lyases in a Marine Bacterium Vibrio alginolyticus LWW-9. Front Microbiol. 2021;12: 696096. https:\/\/doi.org\/10.3389\/fmicb.2021.696096.","journal-title":"Front Microbiol"},{"issue":"Pt A","key":"299_CR115","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ijbiomac.2020.10.011","volume":"165","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang S, Wu H, Wang X, Yu W, Han F. Biochemical characterization of a thermophilic hyaluronate lyase TcHly8C from Thermasporomyces composti DSM22891. Int J Biol Macromol. 2020;165(Pt A):1211\u20138. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.10.011.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"299_CR116","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/1097-0134(20000901)40:4<675::AID-PROT100>3.0.CO;2-H","volume":"40","author":"DG Pritchard","year":"2000","unstructured":"Pritchard DG, Trent JO, Li X, Zhang P, Egan ML, Baker JR. Characterization of the active site of group B streptococcal hyaluronan lyase. Proteins. 2000;40(4):675.","journal-title":"Proteins"},{"key":"299_CR117","doi-asserted-by":"publisher","unstructured":"Giubertoni G, P\u00e9rez de Alba Ort\u00edz A, Bano F, Zhang X, Linhardt RJ, Green DE, et al. Strong Reduction of the Chain Rigidity of Hyaluronan by Selective Binding of Ca2+ Ions. Macromolecules. 2021; 54(3):1137\u201346. https:\/\/doi.org\/10.1021\/acs.macromol.0c02242.","DOI":"10.1021\/acs.macromol.0c02242"},{"key":"299_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2020.100628","volume":"36","author":"N Nantarat","year":"2020","unstructured":"Nantarat N, Mueller M, Lin W-C, Lue S-C, Viernstein H, Chansakaow S, et al. Sesaminol diglucoside isolated from black sesame seed cake and its antioxidant, anti-collagenase and anti-hyaluronidase activities. Food Biosci. 2020;36: 100628. https:\/\/doi.org\/10.1016\/j.fbio.2020.100628.","journal-title":"Food Biosci"},{"key":"299_CR119","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijbiomac.2012.12.047","volume":"55","author":"K Sunitha","year":"2013","unstructured":"Sunitha K, Suresh P, Santhosh MS, Hemshekhar M, Thushara RM, Marathe GK, et al. Inhibition of hyaluronidase by N-acetyl cysteine and glutathione: Role of thiol group in hyaluronan protection. Int J Biol Macromol. 2013;55:39\u201346. https:\/\/doi.org\/10.1016\/j.ijbiomac.2012.12.047.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"299_CR120","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40635-021-00418-3","volume":"9","author":"J van der Heijden","year":"2021","unstructured":"van der Heijden J, Kolliopoulos C, Skorup P, Sallisalmi M, Heldin P, Hultstr\u00f6m M, et al. Plasma hyaluronan, hyaluronidase activity and endogenous hyaluronidase inhibition in sepsis: an experimental and clinical cohort study. Intensive Care Med Exp. 2021;9(1):53. https:\/\/doi.org\/10.1186\/s40635-021-00418-3.","journal-title":"Intensive Care Med Exp"},{"issue":"3","key":"299_CR121","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1165\/rcmb.2007-0361OC","volume":"39","author":"ME Monz\u00f3n","year":"2008","unstructured":"Monz\u00f3n ME, Manzanares D, Schmid N, Casalino-Matsuda SM, Forteza RM. Hyaluronidase Expression and Activity Is Regulated by Pro-Inflammatory Cytokines in Human Airway Epithelial Cells. Am J Respir Cell Mol Biol. 2008;39(3):289\u201395. https:\/\/doi.org\/10.1165\/rcmb.2007-0361OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"299_CR122","doi-asserted-by":"publisher","unstructured":"Jung M, Ma Y, Padmanabhan Iyer R, Yabluchiansky A, Garrett MR, Lindsey ML. Abstract 142: IL-10 Regulates Inflammation to Improve LV Physiology After Myocardial Infarction by Stimulating M2 Macrophage Polarization and Fibroblast Activation. Circ. Res. 2017; 121(suppl_1). https:\/\/doi.org\/10.1161\/res.121.suppl_1.142.","DOI":"10.1161\/res.121.suppl_1.142"},{"key":"299_CR123","doi-asserted-by":"publisher","unstructured":"Lampi MC, Reinhart-King CA. Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials. Sci Transl Med. 2018; 10(422):eaao0475. https:\/\/doi.org\/10.1126\/scitranslmed.aao0475.","DOI":"10.1126\/scitranslmed.aao0475"},{"issue":"15","key":"299_CR124","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1111\/febs.14818","volume":"286","author":"AD Theocharis","year":"2019","unstructured":"Theocharis AD, Manou D, Karamanos NK. The extracellular matrix as a multitasking player in disease. FEBS J. 2019;286(15):2830\u201369. https:\/\/doi.org\/10.1111\/febs.14818.","journal-title":"FEBS J"},{"issue":"4","key":"299_CR125","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.trsl.2013.11.003","volume":"163","author":"BN Brown","year":"2014","unstructured":"Brown BN, Badylak SF. Extracellular matrix as an inductive scaffold for functional tissue reconstruction. Transl Res. 2014;163(4):268\u201385. https:\/\/doi.org\/10.1016\/j.trsl.2013.11.003.","journal-title":"Transl Res"},{"key":"299_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9133-4_1","volume":"1952","author":"D Manou","year":"2019","unstructured":"Manou D, Caon I, Bouris P, Triantaphyllidou I-E, Giaroni C, Passi A, et al. The Complex Interplay Between Extracellular Matrix and Cells in Tissues. Methods Mol Biol. 2019;1952:1\u201320. https:\/\/doi.org\/10.1007\/978-1-4939-9133-4_1.","journal-title":"Methods Mol Biol"},{"issue":"7","key":"299_CR127","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3390\/polym10070701","volume":"10","author":"A Fallacara","year":"2018","unstructured":"Fallacara A, Baldini E, Manfredini S, Vertuani S. Hyaluronic Acid in the Third Millennium. Polymers (Basel). 2018;10(7):701. https:\/\/doi.org\/10.3390\/polym10070701.","journal-title":"Polymers (Basel)"},{"issue":"Pt 24","key":"299_CR128","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1242\/jcs.023820","volume":"123","author":"C Frantz","year":"2010","unstructured":"Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123(Pt 24):4195\u2013200. https:\/\/doi.org\/10.1242\/jcs.023820.","journal-title":"J Cell Sci"},{"issue":"7822","key":"299_CR129","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41586-020-2612-2","volume":"584","author":"O Chaudhuri","year":"2020","unstructured":"Chaudhuri O, Cooper-White J, Janmey PA, Mooney DJ, Shenoy VB. Effects of extracellular matrix viscoelasticity on cellular behaviour. Nature. 2020;584(7822):535\u201346. https:\/\/doi.org\/10.1038\/s41586-020-2612-2.","journal-title":"Nature"},{"key":"299_CR130","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ceb.2021.04.002","volume":"72","author":"A Elosegui-Artola","year":"2021","unstructured":"Elosegui-Artola A. The extracellular matrix viscoelasticity as a regulator of cell and tissue dynamics. Curr Opin Cell Biol. 2021;72:10\u20138. https:\/\/doi.org\/10.1016\/j.ceb.2021.04.002.","journal-title":"Curr Opin Cell Biol"},{"issue":"12","key":"299_CR131","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41580-019-0172-9","volume":"20","author":"KM Yamada","year":"2019","unstructured":"Yamada KM, Sixt M. Mechanisms of 3D cell migration. Nat Rev Mol Cell Biol. 2019;20(12):738\u201352. https:\/\/doi.org\/10.1038\/s41580-019-0172-9.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"299_CR132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12672-023-00618-1","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li L, Wang L, Lu L, Li Y, Huang G, et al. \u2018Two-faces\u2019 of hyaluronan, a dynamic barometer of disease progression in tumor microenvironment. Discov Onc. 2023;14(1):11. https:\/\/doi.org\/10.1007\/s12672-023-00618-1.","journal-title":"Discov Onc"},{"key":"299_CR133","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/563818","volume":"2015","author":"JM Cyphert","year":"2015","unstructured":"Cyphert JM, Trempus CS, Garantziotis S. Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology. Int J Cell Biol. 2015;2015: 563818. https:\/\/doi.org\/10.1155\/2015\/563818.","journal-title":"Int J Cell Biol"},{"issue":"1","key":"299_CR134","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12079-015-0278-6","volume":"9","author":"GJ Fisher","year":"2015","unstructured":"Fisher GJ. Cancer resistance, high molecular weight hyaluronic acid, and longevity. J Cell Commun Signal. 2015;9(1):91\u20132. https:\/\/doi.org\/10.1007\/s12079-015-0278-6.","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"299_CR135","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40001-016-0201-5","volume":"21","author":"BA Buhren","year":"2016","unstructured":"Buhren BA, Schrumpf H, Hoff N-P, B\u00f6lke E, Hilton S, Gerber PA. Hyaluronidase: from clinical applications to molecular and cellular mechanisms. Eur J Med Res. 2016;21(1):5. https:\/\/doi.org\/10.1186\/s40001-016-0201-5.","journal-title":"Eur J Med Res"},{"issue":"15","key":"299_CR136","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1111\/febs.14777","volume":"286","author":"AG Tavianatou","year":"2019","unstructured":"Tavianatou AG, Caon I, Franchi M, Piperigkou Z, Galesso D, Karamanos NK. Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer. FEBS J. 2019;286(15):2883\u2013908. https:\/\/doi.org\/10.1111\/febs.14777.","journal-title":"FEBS J"},{"issue":"4","key":"299_CR137","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1165\/rcmb.2010-0387OC","volume":"45","author":"SL Collins","year":"2011","unstructured":"Collins SL, Black KE, Chan-Li Y, Ahn Y-H, Cole PA, Powell JD, et al. Hyaluronan Fragments Promote Inflammation by Down-Regulating the Anti-inflammatory A2a Receptor. Am J Respir Cell Mol Biol. 2011;45(4):675\u201383. https:\/\/doi.org\/10.1165\/rcmb.2010-0387OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"299_CR138","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/biom11101518","volume":"11","author":"A Marinho","year":"2021","unstructured":"Marinho A, Nunes C, Reis S. Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation. Biomolecules. 2021;11(10):1518. https:\/\/doi.org\/10.3390\/biom11101518.","journal-title":"Biomolecules"},{"issue":"9","key":"299_CR139","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2174\/0929867311320090005","volume":"20","author":"GM Campo","year":"2013","unstructured":"Campo GM, Avenoso A, D\u2019Ascola A, Prestipino V, Scuruchi M, Nastasi G, et al. mer hyaluronan oligosaccharides stimulate inflammation response in synovial fibroblasts in part via TAK-1 and in part via p38-MAPK. Curr Med Chem. 2013;20(9):1162\u201372. https:\/\/doi.org\/10.2174\/0929867311320090005.","journal-title":"Curr Med Chem"},{"issue":"7","key":"299_CR140","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1021\/acsbiomaterials.5b00181","volume":"1","author":"JE Rayahin","year":"2015","unstructured":"Rayahin JE, Buhrman JS, Zhang Y, Koh TJ, Gemeinhart RA. High and low molecular weight hyaluronic acid differentially influence macrophage activation. ACS Biomater Sci Eng. 2015;1(7):481\u201393. https:\/\/doi.org\/10.1021\/acsbiomaterials.5b00181.","journal-title":"ACS Biomater Sci Eng"},{"issue":"3","key":"299_CR141","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"299_CR142","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s44222-022-00004-6","volume":"1","author":"Y Chao","year":"2023","unstructured":"Chao Y, Liu Z. Biomaterials tools to modulate the tumour microenvironment in immunotherapy. Nat Rev Bioeng. 2023;1(2):125\u201338. https:\/\/doi.org\/10.1038\/s44222-022-00004-6.","journal-title":"Nat Rev Bioeng"},{"issue":"8","key":"299_CR143","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s41563-024-01908-x","volume":"23","author":"BL LeSavage","year":"2024","unstructured":"LeSavage BL, Zhang D, Huerta-L\u00f3pez C, Gilchrist AE, Krajina BA, Karlsson K, et al. Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids. Nat Mater. 2024;23(8):1138\u201349. https:\/\/doi.org\/10.1038\/s41563-024-01908-x.","journal-title":"Nat Mater"},{"issue":"5","key":"299_CR144","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00210-023-02840-8","volume":"397","author":"Z Xu","year":"2024","unstructured":"Xu Z. CRISPR\/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(5):2849\u201376. https:\/\/doi.org\/10.1007\/s00210-023-02840-8.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"299_CR145","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ccell.2018.05.003","volume":"33","author":"D Dhar","year":"2018","unstructured":"Dhar D, Antonucci L, Nakagawa H, Kim JY, Glitzner E, Caruso S, et al. Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling. Cancer Cell. 2018;33(6):1061-1077.e6. https:\/\/doi.org\/10.1016\/j.ccell.2018.05.003.","journal-title":"Cancer Cell"},{"issue":"4","key":"299_CR146","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/jocd.12237","volume":"15","author":"NM Salwowska","year":"2016","unstructured":"Salwowska NM, Bebenek KA, \u017b\u0105d\u0142o DA, Wcis\u0142o-Dziadecka DL. Physiochemical properties and application of hyaluronic acid: a systematic review. J Cosmet Dermatol. 2016;15(4):520\u20136. https:\/\/doi.org\/10.1111\/jocd.12237.","journal-title":"J Cosmet Dermatol"},{"issue":"11","key":"299_CR147","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/hep4.1966","volume":"6","author":"L Gong","year":"2022","unstructured":"Gong L, Zhang Y, Yang Y, Yan Q, Ren J, Luo J, et al. Inhibition of lysyl oxidase-like 2 overcomes adhesion-dependent drug resistance in the collagen-enriched liver cancer microenvironment. Hepatol Commun. 2022;6(11):3194\u2013211. https:\/\/doi.org\/10.1002\/hep4.1966.","journal-title":"Hepatol Commun"},{"key":"299_CR148","doi-asserted-by":"publisher","unstructured":"Song Y, Kim J-S, Choi EK, Kim J, Kim KM, Seo HR. TGF-\u03b2-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC. Oncotarget .2017; 8(13):21650\u201362. https:\/\/doi.org\/10.18632\/oncotarget.15521.","DOI":"10.18632\/oncotarget.15521"},{"issue":"1","key":"299_CR149","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.canlet.2015.12.027","volume":"381","author":"M Topalovski","year":"2016","unstructured":"Topalovski M, Brekken RA. Matrix control of pancreatic cancer: New insights into fibronectin signaling. Cancer Lett. 2016;381(1):252\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2015.12.027.","journal-title":"Cancer Lett"},{"issue":"10","key":"299_CR150","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.humpath.2013.03.006","volume":"44","author":"YK Bae","year":"2013","unstructured":"Bae YK, Kim A, Kim MK, Choi JE, Kang SH, Lee SJ. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer. Hum Pathol. 2013;44(10):2028\u201337. https:\/\/doi.org\/10.1016\/j.humpath.2013.03.006.","journal-title":"Hum Pathol"},{"issue":"3","key":"299_CR151","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.apsb.2019.03.001","volume":"9","author":"L Chang","year":"2019","unstructured":"Chang L, Hu Y, Fu Y, Zhou T, You J, Du J, et al. Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells. Acta Pharm Sin B. 2019;9(3):484\u201395. https:\/\/doi.org\/10.1016\/j.apsb.2019.03.001.","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"299_CR152","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/cbin.11390","volume":"44","author":"Y Ye","year":"2020","unstructured":"Ye Y, Zhang R, Feng H. Fibronectin promotes tumor cells growth and drugs resistance through a CDC42-YAP-dependent signaling pathway in colorectal cancer. Cell Biol Int. 2020;44(9):1840\u20139. https:\/\/doi.org\/10.1002\/cbin.11390.","journal-title":"Cell Biol Int"},{"issue":"8","key":"299_CR153","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jcp.31048","volume":"238","author":"F Farooq","year":"2023","unstructured":"Farooq F, Amin A, Wani UM, Lone A, Qadri RA. Shielding and nurturing: Fibronectin as a modulator of cancer drug resistance. Cell Physiol. 2023;238(8):1651\u201369. https:\/\/doi.org\/10.1002\/jcp.31048.","journal-title":"Cell Physiol"},{"issue":"1","key":"299_CR154","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s42003-022-03111-7","volume":"5","author":"L Li","year":"2022","unstructured":"Li L, Li Z, Lu C, Li J, Zhang K, Lin C, et al. Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin \u03b15\/FAK signaling. Commun Biol. 2022;5(1):155. https:\/\/doi.org\/10.1038\/s42003-022-03111-7.","journal-title":"Commun Biol"},{"issue":"10","key":"299_CR155","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1038\/bjc.2014.493","volume":"111","author":"X Wang","year":"2014","unstructured":"Wang X, Zuo D, Chen Y, Li W, Liu R, He Y, et al. Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer. Br J Cancer. 2014;111(10):1965\u201376. https:\/\/doi.org\/10.1038\/bjc.2014.493.","journal-title":"Br J Cancer"},{"issue":"1","key":"299_CR156","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13046-022-02484-1","volume":"41","author":"A Jurj","year":"2022","unstructured":"Jurj A, Ionescu C, Berindan-Neagoe I, Braicu C. The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes? J Exp Clin Cancer Res. 2022;41(1):276. https:\/\/doi.org\/10.1186\/s13046-022-02484-1.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"299_CR157","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37(9):11553\u201372. https:\/\/doi.org\/10.1007\/s13277-016-5098-7.","journal-title":"Tumour Biol"},{"issue":"2","key":"299_CR158","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbcan.2016.03.005","volume":"1865","author":"VS Jones","year":"2016","unstructured":"Jones VS, Huang R-Y, Chen L-P, Chen Z-S, Fu L, Huang R-P. Cytokines in cancer drug resistance: Cues to new therapeutic strategies. Biochim Biophys Acta. 2016;1865(2):255\u201365. https:\/\/doi.org\/10.1016\/j.bbcan.2016.03.005.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"299_CR159","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1742-4658.2011.08071.x","volume":"278","author":"S Misra","year":"2011","unstructured":"Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, et al. Hyaluronan\u2013CD44 interactions as potential targets for cancer therapy. FEBS J. 2011;278(9):1429\u201343. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08071.x.","journal-title":"FEBS J"},{"key":"299_CR160","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.cellbio.23.090506.123337","volume":"23","author":"D Jiang","year":"2007","unstructured":"Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol. 2007;23:435\u201361. https:\/\/doi.org\/10.1146\/annurev.cellbio.23.090506.123337.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"299_CR161","doi-asserted-by":"publisher","unstructured":"Pp P, Sr H. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Br J Cancer. 2013; 108(1). https:\/\/doi.org\/10.1038\/bjc.2012.569.","DOI":"10.1038\/bjc.2012.569"},{"issue":"4","key":"299_CR162","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/2159-8290.CD-11-0136","volume":"1","author":"CJ Whatcott","year":"2011","unstructured":"Whatcott CJ, Han H, Posner RG, Hostetter G, Von Hoff DD. Targeting the tumor microenvironment in cancer: Why hyaluronidase deserves a second look. Cancer Discov. 2011;1(4):291\u20136. https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0136.","journal-title":"Cancer Discov"},{"key":"299_CR163","doi-asserted-by":"publisher","unstructured":"Spinelli FM, Vitale DL, Sevic I, Alaniz L. Hyaluronan in the Tumor Microenvironment. In: Birbrair A, editor. Tumor Microenvironment, vol. 1245, Adv Exp Med Biol.Cham: Springer International Publishing; 2020, p. 67\u201383. https:\/\/doi.org\/10.1007\/978-3-030-40146-7_3.","DOI":"10.1007\/978-3-030-40146-7_3"},{"key":"299_CR164","doi-asserted-by":"publisher","unstructured":"Chanmee T, Ontong P, Itano N. Hyaluronan: Cancer and Cancer Metastasis. In: Taniguchi N, Endo T, Hart GW, Seeberger PH, Wong C-H, editors. Glycoscience: Biology and Medicine, Tokyo: Springer Japan; 2015, p. 1411\u20137. https:\/\/doi.org\/10.1007\/978-4-431-54841-6_191.","DOI":"10.1007\/978-4-431-54841-6_191"},{"issue":"1","key":"299_CR165","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 2021;6(1):153. https:\/\/doi.org\/10.1038\/s41392-021-00544-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"299_CR166","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12272-018-1097-0","volume":"42","author":"N Kaushik","year":"2019","unstructured":"Kaushik N, Kim S, Suh Y, Lee S-J. Proinvasive extracellular matrix remodeling for tumor progression. Arch Pharm Res. 2019;42(1):40\u20137. https:\/\/doi.org\/10.1007\/s12272-018-1097-0.","journal-title":"Arch Pharm Res"},{"key":"299_CR167","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","volume":"6","author":"S Misra","year":"2015","unstructured":"Misra S, Hascall VC, Markwald RR, Ghatak S. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol. 2015;6:201. https:\/\/doi.org\/10.3389\/fimmu.2015.00201.","journal-title":"Front Immunol"},{"issue":"5","key":"299_CR168","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","volume":"15","author":"Z Mai","year":"2024","unstructured":"Mai Z, Lin Y, Lin P, Zhao X, Cui L. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024;15(5):307. https:\/\/doi.org\/10.1038\/s41419-024-06697-4.","journal-title":"Cell Death Dis"},{"issue":"1","key":"299_CR169","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120. https:\/\/doi.org\/10.1038\/s41467-020-18794-x.","journal-title":"Nat Commun"},{"issue":"3","key":"299_CR170","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","volume":"1863","author":"GL Semenza","year":"2016","unstructured":"Semenza GL. The hypoxic tumor microenvironment: A driving force for breast cancer progression. Biochim Biophys Acta. 2016;1863(3):382\u201391. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.05.036.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"299_CR171","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/147323000703500309","volume":"35","author":"FK Isman","year":"2007","unstructured":"Isman FK, Kucur M, Baysal B, Ozkan F. Evaluation of serum hyaluronic acid level and hyaluronidase activity in acute and chronic hepatitis C. J Int Med Res. 2007;35(3):346\u201352. https:\/\/doi.org\/10.1177\/147323000703500309.","journal-title":"J Int Med Res"},{"issue":"6","key":"299_CR172","doi-asserted-by":"publisher","first-page":"901","DOI":"10.4149\/neo_2017_612","volume":"64","author":"Z Liang","year":"2017","unstructured":"Liang Z, Zhang Q, Wang C, Shi F, Cao H, Yu Y, et al. Hyaluronic acid\/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis. Neoplasma. 2017;64(6):901\u20138. https:\/\/doi.org\/10.4149\/neo_2017_612.","journal-title":"Neoplasma"},{"issue":"4","key":"299_CR173","first-page":"778","volume":"57","author":"HT Pham","year":"1997","unstructured":"Pham HT, Block NL, Lokeshwar VB. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Cancer Res. 1997;57(4):778\u201383.","journal-title":"Cancer Res"},{"issue":"1","key":"299_CR174","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12863-022-01070-w","volume":"23","author":"J-P Liu","year":"2022","unstructured":"Liu J-P, Fang Y-T, Jiang Y-F, Lin H. HYAL3 as a potential novel marker of BLCA patient prognosis. BMC Genom Data. 2022;23(1):63. https:\/\/doi.org\/10.1186\/s12863-022-01070-w.","journal-title":"BMC Genom Data"},{"issue":"7","key":"299_CR175","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12032-018-1157-9","volume":"35","author":"I Skarmoutsos","year":"2018","unstructured":"Skarmoutsos I, Skarmoutsos A, Katafigiotis I, Tataki E, Giagini A, Adamakis I, et al. Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer. Med Oncol. 2018;35(7):97. https:\/\/doi.org\/10.1007\/s12032-018-1157-9.","journal-title":"Med Oncol"},{"issue":"1","key":"299_CR176","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ijc.20368","volume":"112","author":"S Ekici","year":"2004","unstructured":"Ekici S, Cerwinka WH, Duncan R, Gomez P, Civantos F, Soloway MS, et al. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. Int J Cancer. 2004;112(1):121\u20139. https:\/\/doi.org\/10.1002\/ijc.20368.","journal-title":"Int J Cancer"},{"issue":"16","key":"299_CR177","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1111\/febs.16600","volume":"290","author":"S Spataro","year":"2023","unstructured":"Spataro S, Guerra C, Cavalli A, Sgrignani J, Sleeman J, Poulain L, et al. CEMIP (HYBID, KIAA1199): structure, function and expression in health and disease. FEBS J. 2023;290(16):3946\u201362. https:\/\/doi.org\/10.1111\/febs.16600.","journal-title":"FEBS J"},{"key":"299_CR178","doi-asserted-by":"publisher","unstructured":"Banach A, Jiang Y-P, Roth E, Kuscu C, Cao J, Lin RZ. CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia. Oncotarget. 2019; 10(42):4307\u201320. https:\/\/doi.org\/10.18632\/oncotarget.27036.","DOI":"10.18632\/oncotarget.27036"},{"key":"299_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.768140","volume":"12","author":"X Dong","year":"2021","unstructured":"Dong X, Yang Y, Yuan Q, Hou J, Wu G. High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker. Front Genet. 2021;12: 768140. https:\/\/doi.org\/10.3389\/fgene.2021.768140.","journal-title":"Front Genet"},{"key":"299_CR180","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2407-13-181","volume":"13","author":"H Siiskonen","year":"2013","unstructured":"Siiskonen H, Poukka M, Tyynel\u00e4-Korhonen K, Sironen R, Pasonen-Sepp\u00e4nen S. Inverse expression of hyaluronidase 2 and hyaluronan synthases 1\u20133 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer. 2013;13:181. https:\/\/doi.org\/10.1186\/1471-2407-13-181.","journal-title":"BMC Cancer"},{"issue":"15","key":"299_CR181","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.3390\/cancers15153813","volume":"15","author":"A Parnigoni","year":"2023","unstructured":"Parnigoni A, Moretto P, Viola M, Karousou E, Passi A, Vigetti D. Effects of Hyaluronan on Breast Cancer Aggressiveness. Cancers (Basel). 2023;15(15):3813. https:\/\/doi.org\/10.3390\/cancers15153813.","journal-title":"Cancers (Basel)"},{"issue":"17","key":"299_CR182","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1158\/0008-5472.CAN-15-2322","volume":"76","author":"H Lee","year":"2016","unstructured":"Lee H, Goodarzi H, Tavazoie SF, Alarc\u00f3n CR. TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast Cancer. Cancer Res. 2016;76(17):4994\u20135005. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2322.","journal-title":"Cancer Res"},{"issue":"3","key":"299_CR183","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ijc.11252","volume":"106","author":"EJ Franzmann","year":"2003","unstructured":"Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer. 2003;106(3):438\u201345. https:\/\/doi.org\/10.1002\/ijc.11252.","journal-title":"Int J Cancer"},{"issue":"6","key":"299_CR184","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/coa.13390","volume":"44","author":"HC \u0130nan","year":"2019","unstructured":"\u0130nan HC, Yener M, Buyru N, \u00c7elebi A, Yilmaz M, \u00c7omuno\u011flu N. The investigation of hyaluronic acid and hyaluronidase-1 levels as tumour marker in larynx cancer. Clin Otolaryngol. 2019;44(6):914\u20138. https:\/\/doi.org\/10.1111\/coa.13390.","journal-title":"Clin Otolaryngol"},{"key":"299_CR185","doi-asserted-by":"publisher","unstructured":"Schott S, Yang R, St\u00f6cker S, Canzian F, Giese N, Bugert P, et al. HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study. Oncotarget. 2017; 8(40):67614\u201325. https:\/\/doi.org\/10.18632\/oncotarget.18757.","DOI":"10.18632\/oncotarget.18757"},{"issue":"4","key":"299_CR186","doi-asserted-by":"publisher","first-page":"664","DOI":"10.4103\/jcrt.JCRT_61_17","volume":"13","author":"F Deng","year":"2017","unstructured":"Deng F, Lei J, Zhang X, Huang W, Li Y, Wu D. Overexpression of KIAA1199: An independent prognostic marker in nonsmall cell lung cancer. J Cancer Res Ther. 2017;13(4):664\u20138. https:\/\/doi.org\/10.4103\/jcrt.JCRT_61_17.","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"299_CR187","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175058","volume":"12","author":"S Jia","year":"2017","unstructured":"Jia S, Qu T, Wang X, Feng M, Yang Y, Feng X, et al. KIAA1199 promotes migration and invasion by Wnt\/\u03b2-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer. PLoS ONE. 2017;12(4): e0175058. https:\/\/doi.org\/10.1371\/journal.pone.0175058.","journal-title":"PLoS ONE"},{"issue":"7","key":"299_CR188","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1749-6632.1950.tb54007.x","volume":"52","author":"B Sallman","year":"1950","unstructured":"Sallman B, Birkeland JM. THE ROLE OF HYALURONIDASE IN HEMOLYTIC STREPTOCOCCAL INFECTION. Ann Ny Acad Sci. 1950;52(7):1062\u20139. https:\/\/doi.org\/10.1111\/j.1749-6632.1950.tb54007.x.","journal-title":"Ann Ny Acad Sci"},{"key":"299_CR189","doi-asserted-by":"publisher","unstructured":"Coleman M, Armistead B, Orvis A, Quach P, Brokaw A, Gendrin C, et al. Hyaluronidase Impairs Neutrophil Function and Promotes Group B Streptococcus Invasion and Preterm Labor in Nonhuman Primates. mBio. 2021; 12(1):e03115\u201320. https:\/\/doi.org\/10.1128\/mBio.03115-20.","DOI":"10.1128\/mBio.03115-20"},{"key":"299_CR190","doi-asserted-by":"publisher","first-page":"71S","DOI":"10.1111\/j.1365-2672.1990.tb01799.x","volume":"19","author":"LA Devriese","year":"1990","unstructured":"Devriese LA. Staphylococci in healthy and diseased animals. Soc Appl Bacteriol Symp Ser. 1990;19:71S-80S. https:\/\/doi.org\/10.1111\/j.1365-2672.1990.tb01799.x.","journal-title":"Soc Appl Bacteriol Symp Ser"},{"issue":"6","key":"299_CR191","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1128\/IAI.01418-15","volume":"84","author":"CB Ibberson","year":"2016","unstructured":"Ibberson CB, Parlet CP, Kwiecinski J, Crosby HA, Meyerholz DK, Horswill AR. Hyaluronan Modulation Impacts Staphylococcus aureus Biofilm Infection. Infect Immun. 2016;84(6):1917\u201329. https:\/\/doi.org\/10.1128\/IAI.01418-15.","journal-title":"Infect Immun"},{"issue":"3","key":"299_CR192","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/ard.58.3.186","volume":"58","author":"H Nagaya","year":"1999","unstructured":"Nagaya H, Ymagata T, Ymagata S, Iyoda K, Ito H, Hasegawa Y, et al. Examination of synovial fluid and serum hyaluronidase activity as a joint marker in rheumatoid arthritis and osteoarthritis patients (by zymography). Ann Rheum Dis. 1999;58(3):186\u20138. https:\/\/doi.org\/10.1136\/ard.58.3.186.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"299_CR193","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1756-185X.2011.01683.x","volume":"14","author":"Y Sasaki","year":"2011","unstructured":"Sasaki Y, Uzuki M, Nohmi K, Kitagawa H, Kamataki A, Komagamine M, et al. Quantitative measurement of serum hyaluronic acid molecular weight in rheumatoid arthritis patients and the role of hyaluronidase. Int J Rheum Dis. 2011;14(4):313\u20139. https:\/\/doi.org\/10.1111\/j.1756-185X.2011.01683.x.","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"299_CR194","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1365-2133.2004.05805.x","volume":"150","author":"BA Neudecker","year":"2004","unstructured":"Neudecker BA, Stern R, Connolly MK. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma. Br J Dermatol. 2004;150(3):469\u201376. https:\/\/doi.org\/10.1046\/j.1365-2133.2004.05805.x.","journal-title":"Br J Dermatol"},{"issue":"9","key":"299_CR195","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.2337\/db15-1662","volume":"65","author":"S Dogn\u00e9","year":"2016","unstructured":"Dogn\u00e9 S, Rath G, Jouret F, Caron N, Dessy C, Flamion B. Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced Diabetes. Diabetes. 2016;65(9):2742\u201353. https:\/\/doi.org\/10.2337\/db15-1662.","journal-title":"Diabetes"},{"issue":"9","key":"299_CR196","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1182\/blood.2018893594","volume":"134","author":"AC Petrey","year":"2019","unstructured":"Petrey AC, Obery DR, Kessler SP, Zawerton A, Flamion B, de la Motte CA. Platelet hyaluronidase-2 regulates the early stages of inflammatory disease in colitis. Blood. 2019;134(9):765\u201375. https:\/\/doi.org\/10.1182\/blood.2018893594.","journal-title":"Blood"},{"key":"299_CR197","unstructured":"Kunder EV. Criteria for the differential diagnosis of spondyloarthropathies, by determining serum hyaluronidase activity. Klin Lab Diagn. 2010: (4)10\u20132."},{"issue":"1","key":"299_CR198","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/08037051.2014.940708","volume":"24","author":"B Karadag","year":"2015","unstructured":"Karadag B, Ikitimur B, Firinciogullari H, Cakmak HA, Cosansu K, Yuksel H. The relationship between aortic stiffness and serum hyaluronidase levels in patients with diabetes mellitus and hypertension. Blood Press. 2015;24(1):35\u201340. https:\/\/doi.org\/10.3109\/08037051.2014.940708.","journal-title":"Blood Press"},{"key":"299_CR199","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.matbio.2016.11.003","volume":"62","author":"VK Krishnamurthy","year":"2017","unstructured":"Krishnamurthy VK, Stout AJ, Sapp MC, Matuska B, Lauer ME, Grande-Allen KJ. Dysregulation of hyaluronan homeostasis during aortic valve disease. Matrix Biol. 2017;62:40\u201357. https:\/\/doi.org\/10.1016\/j.matbio.2016.11.003.","journal-title":"Matrix Biol"},{"issue":"1","key":"299_CR200","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1074\/jbc.M112.393629","volume":"288","author":"B Chowdhury","year":"2013","unstructured":"Chowdhury B, Hemming R, Hombach-Klonisch S, Flamion B, Triggs-Raine B. Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunction. J Biol Chem. 2013;288(1):520\u20138. https:\/\/doi.org\/10.1074\/jbc.M112.393629.","journal-title":"J Biol Chem"},{"issue":"1","key":"299_CR201","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001598","volume":"10","author":"B Chowdhury","year":"2017","unstructured":"Chowdhury B, Xiang B, Liu M, Hemming R, Dolinsky VW, Triggs-Raine B. Hyaluronidase 2 Deficiency Causes Increased Mesenchymal Cells, Congenital Heart Defects, and Heart Failure. Circ Cardiovasc Genet. 2017;10(1): e001598. https:\/\/doi.org\/10.1161\/CIRCGENETICS.116.001598.","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"299_CR202","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.athoracsur.2020.01.025","volume":"110","author":"HN Al Kindi","year":"2020","unstructured":"Al Kindi HN, Shehata M, Ibrahim AM, Roshdy M, Simry W, Aguib Y, et al. Cor Triatriatum Sinister (Divided Left Atrium): Histopathologic Features and Clinical Management. Ann Thorac Surg. 2020;110(4):1380\u20136. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.01.025.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"299_CR203","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"M Jung","year":"2017","unstructured":"Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112(3):33. https:\/\/doi.org\/10.1007\/s00395-017-0622-5.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"299_CR204","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1165\/ajrcmb.23.3.4102","volume":"23","author":"Y Li","year":"2000","unstructured":"Li Y, Rahmanian M, Widstr\u00f6m C, Lepperdinger G, Frost GI, Heldin P. Irradiation-Induced Expression of Hyaluronan (HA) Synthase 2 and Hyaluronidase 2 Genes in Rat Lung Tissue Accompanies Active Turnover of HA and Induction of Types I and III Collagen Gene Expression. Am J Respir Cell Mol Biol. 2000;23(3):411\u20138. https:\/\/doi.org\/10.1165\/ajrcmb.23.3.4102.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"299_CR205","doi-asserted-by":"publisher","first-page":"19484","DOI":"10.1038\/s41598-020-74769-4","volume":"10","author":"M Meszaros","year":"2020","unstructured":"Meszaros M, Kis A, Kunos L, Tarnoki AD, Tarnoki DL, Lazar Z, et al. The role of hyaluronic acid and hyaluronidase-1 in obstructive sleep apnoea. Sci Rep. 2020;10(1):19484. https:\/\/doi.org\/10.1038\/s41598-020-74769-4.","journal-title":"Sci Rep"},{"issue":"6","key":"299_CR206","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1378\/chest.15-0153","volume":"148","author":"E Papakonstantinou","year":"2015","unstructured":"Papakonstantinou E, Roth M, Klagas I, Karakiulakis G, Tamm M, Stolz D. COPD Exacerbations Are Associated With Proinflammatory Degradation of Hyaluronic Acid. Chest. 2015;148(6):1497\u2013507. https:\/\/doi.org\/10.1378\/chest.15-0153.","journal-title":"Chest"},{"issue":"19","key":"299_CR207","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1111\/bph.13947","volume":"174","author":"SD Collum","year":"2017","unstructured":"Collum SD, Chen N-Y, Hernandez AM, Hanmandlu A, Sweeney H, Mertens TCJ, et al. Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis. Br J Pharmacol. 2017;174(19):3284\u2013301. https:\/\/doi.org\/10.1111\/bph.13947.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"299_CR208","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1096\/fj.201901583R","volume":"34","author":"L Li","year":"2020","unstructured":"Li L, Tian F-Y, Yuan Y, Zhang T, Yang W-B, Kong R, et al. HYAL-1-induced autophagy facilitates pancreatic fistula for patients who underwent pancreaticoduodenectomy. FASEB J. 2020;34(2):2524\u201340. https:\/\/doi.org\/10.1096\/fj.201901583R.","journal-title":"FASEB J"},{"issue":"1\u20132","key":"299_CR209","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cccn.2004.05.018","volume":"348","author":"J George","year":"2004","unstructured":"George J, Stern R. Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury. Clin Chim Acta. 2004;348(1\u20132):189\u201397. https:\/\/doi.org\/10.1016\/j.cccn.2004.05.018.","journal-title":"Clin Chim Acta"},{"key":"299_CR210","doi-asserted-by":"publisher","unstructured":"Mustonen A-M, Salv\u00e9n A, K\u00e4rj\u00e4 V, Rilla K, Matilainen J, Nieminen P. Hyaluronan histochemistry-a potential new tool to assess the progress of liver disease from simple steatosis to hepatocellular carcinoma. Glycobiology. 2019; 29(4:298\u2013306. https:\/\/doi.org\/10.1093\/glycob\/cwz002.","DOI":"10.1093\/glycob\/cwz002"},{"issue":"8","key":"299_CR211","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1080\/15548627.2023.2181614","volume":"19","author":"S-H Kim","year":"2023","unstructured":"Kim S-H, Cho Y-S, Kim Y, Park J, Yoo S-M, Gwak J, et al. Endolysosomal impairment by binding of amyloid beta or MAPT\/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease. Autophagy. 2023;19(8):2318\u201337. https:\/\/doi.org\/10.1080\/15548627.2023.2181614.","journal-title":"Autophagy"},{"issue":"5","key":"299_CR212","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/exd.12147","volume":"22","author":"GP Sidgwick","year":"2013","unstructured":"Sidgwick GP, Iqbal SA, Bayat A. Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin. Exp Dermatol. 2013;22(5):377\u20139. https:\/\/doi.org\/10.1111\/exd.12147.","journal-title":"Exp Dermatol"},{"issue":"3","key":"299_CR213","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.jid.5700614","volume":"127","author":"M Averbeck","year":"2007","unstructured":"Averbeck M, Gebhardt CA, Voigt S, Beilharz S, Anderegg U, Termeer CC, et al. Differential regulation of hyaluronan metabolism in the epidermal and dermal compartments of human skin by UVB irradiation. J Invest Dermatol. 2007;127(3):687\u201397. https:\/\/doi.org\/10.1038\/sj.jid.5700614.","journal-title":"J Invest Dermatol"},{"issue":"18","key":"299_CR214","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2174\/092986709788453078","volume":"16","author":"KS Girish","year":"2009","unstructured":"Girish KS, Kemparaju K, Nagaraju S, Vishwanath BS. Hyaluronidase inhibitors: a biological and therapeutic perspective. Curr Med Chem. 2009;16(18):2261\u201388. https:\/\/doi.org\/10.2174\/092986709788453078.","journal-title":"Curr Med Chem"},{"key":"299_CR215","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0021-9258(17)41347-0","volume":"163","author":"E Haas","year":"1946","unstructured":"Haas E. On the mechanism of invasion; antinvasin I, an enzyme in plasma. J Biol Chem. 1946;163:63\u201388.","journal-title":"J Biol Chem"},{"issue":"42","key":"299_CR216","doi-asserted-by":"publisher","first-page":"32413","DOI":"10.1074\/jbc.M005428200","volume":"275","author":"K Mio","year":"2000","unstructured":"Mio K, Carrette O, Maibach HI, Stern R. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-alpha-inhibitor family. J Biol Chem. 2000;275(42):32413\u201321. https:\/\/doi.org\/10.1074\/jbc.M005428200.","journal-title":"J Biol Chem"},{"issue":"7","key":"299_CR217","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/0002-9149(84)90529-0","volume":"53","author":"RA Wolf","year":"1984","unstructured":"Wolf RA, Glogar D, Chaung LY, Garrett PE, Ertl G, Tumas J, et al. Heparin inhibits bovine testicular hyaluronidase activity in myocardium of dogs with coronary artery occlusion. Am J Cardiol. 1984;53(7):941\u20134. https:\/\/doi.org\/10.1016\/0002-9149(84)90529-0.","journal-title":"Am J Cardiol"},{"issue":"1","key":"299_CR218","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0939-6411(00)00136-3","volume":"51","author":"AV Maksimenko","year":"2001","unstructured":"Maksimenko AV, Petrova ML, Tischenko EG, Schechilina YV. Chemical modification of hyaluronidase regulates its inhibition by heparin. Eur J Pharm Biopharm. 2001;51(1):33\u20138. https:\/\/doi.org\/10.1016\/s0939-6411(00)00136-3.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"299_CR219","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1006\/abbi.1999.1395","volume":"370","author":"T Toida","year":"1999","unstructured":"Toida T, Ogita Y, Suzuki A, Toyoda H, Imanari T. Inhibition of hyaluronidase by fully O-sulfonated glycosaminoglycans. Arch Biochem Biophys. 1999;370(2):176\u201382. https:\/\/doi.org\/10.1006\/abbi.1999.1395.","journal-title":"Arch Biochem Biophys"},{"issue":"20","key":"299_CR220","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1016\/j.bmcl.2006.07.087","volume":"6","author":"M Spickenreither","year":"2006","unstructured":"Spickenreither M, Braun S, Bernhardt G, Dove S, Buschauer A. Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases. B Bioorg Med Chem Let. 2006;6(20):5313\u20136. https:\/\/doi.org\/10.1016\/j.bmcl.2006.07.087.","journal-title":"B Bioorg Med Chem Let"},{"issue":"13","key":"299_CR221","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.lfs.2005.07.015","volume":"78","author":"KS Girish","year":"2006","unstructured":"Girish KS, Kemparaju K. Inhibition of Naja naja venom hyaluronidase: Role in the management of poisonous bite. Life Sci. 2006;78(13):1433\u201340. https:\/\/doi.org\/10.1016\/j.lfs.2005.07.015.","journal-title":"Life Sci"},{"issue":"2","key":"299_CR222","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0006-2952(90)90709-t","volume":"40","author":"UR Kuppusamy","year":"1990","unstructured":"Kuppusamy UR, Khoo HE, Das NP. Structure-activity studies of flavonoids as inhibitors of hyaluronidase. Biochem Pharmacol. 1990;40(2):397\u2013401. https:\/\/doi.org\/10.1016\/0006-2952(90)90709-t.","journal-title":"Biochem Pharmacol"},{"key":"299_CR223","doi-asserted-by":"publisher","unstructured":"Cho KHT, Hounsell N, McClendon E, Riddle A, Basappa, Dhillon SK, et al. Postischemic Infusion of Apigenin Reduces Seizure Burden in Preterm Fetal Sheep. IJMS. 2023; 24(23):16926. https:\/\/doi.org\/10.3390\/ijms242316926.","DOI":"10.3390\/ijms242316926"},{"issue":"1","key":"299_CR224","doi-asserted-by":"publisher","first-page":"14958","DOI":"10.1038\/s41598-024-64924-6","volume":"14","author":"J McGuire","year":"2024","unstructured":"McGuire J, Taguchi T, Tombline G, Paige V, Janelsins M, Gilmore N, et al. Hyaluronidase inhibitor delphinidin inhibits cancer metastasis. Sci Rep. 2024;14(1):14958. https:\/\/doi.org\/10.1038\/s41598-024-64924-6.","journal-title":"Sci Rep"},{"key":"299_CR225","doi-asserted-by":"publisher","unstructured":"Sato T, Matsuda T, Tagawa K, Segawa S. \u03b1-ketoglutarate produced by lactic acid bacteria inhibits hyaluronidase activity. Biosci Microbiota Food Health. 2024; 43(4):391\u2013400. https:\/\/doi.org\/10.12938\/bmfh.2024-017.","DOI":"10.12938\/bmfh.2024-017"},{"issue":"8","key":"299_CR226","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/humrep\/den212","volume":"23","author":"A De Vos","year":"2008","unstructured":"De Vos A, Van Landuyt L, Van Ranst H, Vandermonde A, D\u2019Haese V, Sterckx J, et al. Randomized sibling-oocyte study using recombinant human hyaluronidase versus bovine-derived Sigma hyaluronidase in ICSI patients. Hum Reprod. 2008;23(8):1815\u20139. https:\/\/doi.org\/10.1093\/humrep\/den212.","journal-title":"Hum Reprod"},{"issue":"2","key":"299_CR227","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5187\/jast.2021.e34","volume":"63","author":"JH Lee","year":"2021","unstructured":"Lee JH, Yoo M, Lee SM, Park S-J, Kil TY, Kim MK. Toxicity of the recombinant human hyaluronidase ALT-BC4 on embryonic development. J Anim Sci Technol. 2021;63(2):272\u201380. https:\/\/doi.org\/10.5187\/jast.2021.e34.","journal-title":"J Anim Sci Technol"},{"key":"299_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122122","volume":"625","author":"Y Chen","year":"2022","unstructured":"Chen Y, Feng X. Gold nanoparticles for skin drug delivery. Int J Pharm. 2022;625: 122122. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122122.","journal-title":"Int J Pharm"},{"issue":"2","key":"299_CR229","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324. https:\/\/doi.org\/10.1038\/s41573-020-0090-8.","journal-title":"Nat Rev Drug Discov"},{"key":"299_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123976","volume":"654","author":"LS Devi","year":"2024","unstructured":"Devi LS, Casadidio C, Gigliobianco MR, Di Martino P, Censi R. Multifunctionality of cyclodextrin-based polymeric nanoparticulate delivery systems for chemotherapeutics, combination therapy, and theranostics. Int J Pharm. 2024;654: 123976. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123976.","journal-title":"Int J Pharm"},{"issue":"1","key":"299_CR231","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/10408398.2022.2105800","volume":"64","author":"Y Meng","year":"2024","unstructured":"Meng Y, Qiu C, Li X, McClements DJ, Sang S, Jiao A, et al. Polysaccharide-based nano-delivery systems for encapsulation, delivery, and pH-responsive release of bioactive ingredients. Crit Rev Food Sci Nutr. 2024;64(1):187\u2013201. https:\/\/doi.org\/10.1080\/10408398.2022.2105800.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"299_CR232","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.2147\/IJN.S257164","volume":"15","author":"E Chen","year":"2020","unstructured":"Chen E, Han S, Song B, Xu L, Yuan H, Liang M, et al. Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect. Int J Nanomedicine. 2020;15:6311\u201324. https:\/\/doi.org\/10.2147\/IJN.S257164.","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"299_CR233","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1021\/acs.molpharmaceut.0c00294","volume":"17","author":"R Soundararajan","year":"2020","unstructured":"Soundararajan R, Wang G, Petkova A, Uchegbu IF, Sch\u00e4tzlein AG. Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route. Mol Pharm. 2020;17(7):2599\u2013611. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00294.","journal-title":"Mol Pharm"},{"issue":"16","key":"299_CR234","doi-asserted-by":"publisher","first-page":"18273","DOI":"10.1021\/acsami.0c00355","volume":"12","author":"S Yin","year":"2020","unstructured":"Yin S, Gao Y, Zhang Y, Xu J, Zhu J, Zhou F, et al. Reduction\/Oxidation-Responsive Hierarchical Nanoparticles with Self-Driven Degradability for Enhanced Tumor Penetration and Precise Chemotherapy. ACS Appl Mater Interfaces. 2020;12(16):18273\u201391. https:\/\/doi.org\/10.1021\/acsami.0c00355.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"299_CR235","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.drudis.2021.07.010","volume":"26","author":"PK Parmar","year":"2021","unstructured":"Parmar PK, Wadhawan J, Bansal AK. Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery. Drug Discovery Today. 2021;26(10):2329\u201349. https:\/\/doi.org\/10.1016\/j.drudis.2021.07.010.","journal-title":"Drug Discovery Today"},{"key":"299_CR236","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/948650","volume":"2014","author":"N Kasinathan","year":"2014","unstructured":"Kasinathan N, Volety SM, Josyula VR. Application of experimental design in preparation of nanoliposomes containing hyaluronidase. J Drug Deliv. 2014;2014: 948650. https:\/\/doi.org\/10.1155\/2014\/948650.","journal-title":"J Drug Deliv"},{"key":"299_CR237","doi-asserted-by":"publisher","unstructured":"Ikeda-Imafuku M, Gao Y, Shaha S, Wang LL-W, Park KS, Nakajima M, et al. Extracellular matrix degrading enzyme with stroma-targeting peptides enhance the penetration of liposomes into tumors. J Control Release. 2022;352:1093\u2013103. https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.007.","DOI":"10.1016\/j.jconrel.2022.11.007"},{"key":"299_CR238","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.urology.2016.07.007","volume":"98","author":"LA Favorito","year":"2016","unstructured":"Favorito LA, Gallo CBM, Costa WS, Sampaio FJB. Ultrastructural Analysis of the Foreskin in Patients With True Phimosis Treated or Not Treated With Topical Betamethasone and Hyaluronidase Ointment. Urology. 2016;98:138\u201343. https:\/\/doi.org\/10.1016\/j.urology.2016.07.007.","journal-title":"Urology"},{"key":"299_CR239","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.colsurfb.2019.04.028","volume":"179","author":"S Ohta","year":"2019","unstructured":"Ohta S, Matsuura M, Kawashima Y, Cai X, Taniguchi M, Okochi H, et al. Facile fabrication of PEG-coated PLGA microspheres via SPG membrane emulsification for the treatment of scleroderma by ECM degrading enzymes. Colloids Surf B Biointerfaces. 2019;179:453\u201361. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.04.028.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"299_CR240","doi-asserted-by":"publisher","first-page":"205031212110343","DOI":"10.1177\/20503121211034366","volume":"9","author":"DT Debela","year":"2021","unstructured":"Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021;9:20503121211034370. https:\/\/doi.org\/10.1177\/20503121211034366.","journal-title":"SAGE Open Med"},{"key":"299_CR241","doi-asserted-by":"publisher","first-page":"8481761","DOI":"10.1155\/2024\/8481761","volume":"2024","author":"AN Oli","year":"2024","unstructured":"Oli AN, Adejumo SA, Rowaiye AB, Ogidigo JO, Hampton-Marcell J, Ibeanu GC. Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature. J Immunol Res. 2024;2024:8481761. https:\/\/doi.org\/10.1155\/2024\/8481761.","journal-title":"J Immunol Res"},{"issue":"8","key":"299_CR242","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807\u201321. https:\/\/doi.org\/10.1038\/s41423-020-0488-6.","journal-title":"Cell Mol Immunol"},{"key":"299_CR243","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","volume":"62","author":"KM Hargadon","year":"2018","unstructured":"Hargadon KM, Johnson CE, Williams CJ. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors. Int Immunopharmacol. 2018;62:29\u201339. https:\/\/doi.org\/10.1016\/j.intimp.2018.06.001.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"299_CR244","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/cancers12030738","volume":"12","author":"RK Vaddepally","year":"2020","unstructured":"Vaddepally RK, Kharel P, Pandey R, Garje R, Chandra AB. Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence. Cancers (Basel). 2020;12(3):738. https:\/\/doi.org\/10.3390\/cancers12030738.","journal-title":"Cancers (Basel)"},{"issue":"6230","key":"299_CR245","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348(6230):62\u20138. https:\/\/doi.org\/10.1126\/science.aaa4967.","journal-title":"Science"},{"issue":"7971","key":"299_CR246","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","volume":"619","author":"DJ Baker","year":"2023","unstructured":"Baker DJ, Arany Z, Baur JA, Epstein JA, June CH. CAR T therapy beyond cancer: the evolution of a living drug. Nature. 2023;619(7971):707\u201315. https:\/\/doi.org\/10.1038\/s41586-023-06243-w.","journal-title":"Nature"},{"key":"299_CR247","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-019-0070-9","volume":"4","author":"D Li","year":"2019","unstructured":"Li D, Li X, Zhou W-L, Huang Y, Liang X, Jiang L, et al. Genetically engineered T cells for cancer immunotherapy. Signal Transduct Target Ther. 2019;4:35. https:\/\/doi.org\/10.1038\/s41392-019-0070-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"299_CR248","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1172\/JCI80009","volume":"125","author":"CJM Melief","year":"2015","unstructured":"Melief CJM, van Hall T, Arens R, Ossendorp F, van der Burg SH. Therapeutic cancer vaccines. J Clin Invest. 2015;125(9):3401\u201312. https:\/\/doi.org\/10.1172\/JCI80009.","journal-title":"J Clin Invest"},{"key":"299_CR249","doi-asserted-by":"publisher","unstructured":"Wang X, Maeng HM, Lee J, Xie C. Therapeutic implementation of oncolytic viruses for cancer immunotherapy: Review of challenges and current clinical trials. J Biomed Sci Res. 2022; 4(2):164. https:\/\/doi.org\/10.36266\/JBSR\/164.","DOI":"10.36266\/JBSR\/164"},{"issue":"12","key":"299_CR250","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028472","volume":"10","author":"TA Waldmann","year":"2018","unstructured":"Waldmann TA. Cytokines in Cancer Immunotherapy. Cold Spring Harb Perspect Biol. 2018;10(12): a028472. https:\/\/doi.org\/10.1101\/cshperspect.a028472.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"16","key":"299_CR251","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1158\/0008-5472.CAN-18-3060","volume":"79","author":"R Clift","year":"2019","unstructured":"Clift R, Souratha J, Garrovillo SA, Zimmerman S, Blouw B. Remodeling the tumor microenvironment sensitizes breast tumors to anti-programmed death-ligand 1 immunotherapy. Cancer Res. 2019;79(16):4149\u201359. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3060.","journal-title":"Cancer Res"},{"key":"299_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122253","volume":"301","author":"M Yang","year":"2023","unstructured":"Yang M, Qin C, Tao L, Cheng G, Li J, Lv F, et al. Synchronous targeted delivery of TGF-\u03b2 siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment. Biomaterials. 2023;301: 122253. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122253.","journal-title":"Biomaterials"},{"issue":"5","key":"299_CR253","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/gels8050284","volume":"8","author":"A Harui","year":"2022","unstructured":"Harui A, Roth MD. Hyaluronidase enhances targeting of hydrogel-encapsulated anti-CTLA-4 to tumor draining lymph nodes and improves anti-tumor efficacy. Gels. 2022;8(5):284. https:\/\/doi.org\/10.3390\/gels8050284.","journal-title":"Gels"},{"key":"299_CR254","doi-asserted-by":"publisher","unstructured":"Moeller J, Green MD, Ramnath N. Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer. Transl Lung Cancer Res. 2024;13(6):1444\u20131449. https:\/\/doi.org\/10.21037\/tlcr-24-111.","DOI":"10.21037\/tlcr-24-111"},{"issue":"3","key":"299_CR255","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/cpt.3148","volume":"115","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Sanghavi K, Roy A, Murthy B, Bello A, Aras U, et al. Model-Based Dose Selection of Subcutaneous Nivolumab in Patients with Advanced Solid Tumors. Clin Pharmacol Ther. 2024;115(3):488\u201397. https:\/\/doi.org\/10.1002\/cpt.3148.","journal-title":"Clin Pharmacol Ther"},{"key":"299_CR256","doi-asserted-by":"publisher","unstructured":"Albiges L, Bourlon MT, Chac\u00f3n M, Cutuli HJ, Chuken Y a. L, \u017burawski B, et al. Subcutaneous versus intravenous nivolumab for renal cell carcinoma. Ann Oncol. 2025; 36(1):99\u2013107. https:\/\/doi.org\/10.1016\/j.annonc.2024.09.002.","DOI":"10.1016\/j.annonc.2024.09.002"},{"issue":"3","key":"299_CR257","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1060028019877936","volume":"54","author":"MR Duco","year":"2020","unstructured":"Duco MR, Murdock JL, Reeves DJ. Trastuzumab\/Hyaluronidase-oysk: A New Option for Patients With HER2-Positive Breast Cancer. Ann Pharmacother. 2020;54(3):254\u201361. https:\/\/doi.org\/10.1177\/1060028019877936.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"299_CR258","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMoa2312054","volume":"390","author":"P Sonneveld","year":"2024","unstructured":"Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, et al. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. N Engl J Med. 2024;390(4):301\u201313. https:\/\/doi.org\/10.1056\/NEJMoa2312054.","journal-title":"N Engl J Med"},{"issue":"8","key":"299_CR259","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1158\/1078-0432.CCR-20-3474","volume":"27","author":"JJ Gao","year":"2021","unstructured":"Gao JJ, Osgood CL, Gong Y, Zhang H, Bloomquist EW, Jiang X, et al. FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer. Clin Cancer Res. 2021;27(8):2126\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3474.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"299_CR260","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/bjc.2013.371","volume":"109","author":"O Shpilberg","year":"2013","unstructured":"Shpilberg O, Jackisch C. Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase. Br J Cancer. 2013;109(6):1556\u201361. https:\/\/doi.org\/10.1038\/bjc.2013.371.","journal-title":"Br J Cancer"},{"issue":"8","key":"299_CR261","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s11095-022-03294-y","volume":"39","author":"X Gao","year":"2022","unstructured":"Gao X, Lee J, Deshpande K, Kang DW, Fathallah AM, Kagan L. Mechanistic Modeling of the Effect of Recombinant Human Hyaluronidase (rHuPH20) on Subcutaneous Delivery of Cetuximab in Rats. Pharm Res. 2022;39(8):1867\u201380. https:\/\/doi.org\/10.1007\/s11095-022-03294-y.","journal-title":"Pharm Res"},{"issue":"5","key":"299_CR262","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/liv.14771","volume":"41","author":"X Xiong","year":"2021","unstructured":"Xiong X, Xi J, Liu Q, Wang C, Jiang Z, Yue S-Y, et al. Co-expression of IL-7 and PH20 promote anti-GPC3 CAR-T tumour suppressor activity in vivo and in vitro. Liver Int. 2021;41(5):1033\u201343. https:\/\/doi.org\/10.1111\/liv.14771.","journal-title":"Liver Int"},{"issue":"5","key":"299_CR263","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1021\/acscentsci.2c00163","volume":"8","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Dong Y, Yang S, Tu Y, Wang C, Li J, et al. Bioorthogonal equipping CAR-T cells with hyaluronidase and checkpoint blocking antibody for enhanced solid tumor immunotherapy. ACS Cent Sci. 2022;8(5):603\u201314. https:\/\/doi.org\/10.1021\/acscentsci.2c00163.","journal-title":"ACS Cent Sci"},{"key":"299_CR264","doi-asserted-by":"publisher","unstructured":"Chow EK-H, Ho D. Cancer nanomedicine: From drug delivery to imaging. Sci Transl Med. 2013; 5(216):216rv4. https:\/\/doi.org\/10.1126\/scitranslmed.3005872.","DOI":"10.1126\/scitranslmed.3005872"},{"issue":"2","key":"299_CR265","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.onc.1210911","volume":"27","author":"AM Krieg","year":"2008","unstructured":"Krieg AM. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene. 2008;27(2):161\u20137. https:\/\/doi.org\/10.1038\/sj.onc.1210911.","journal-title":"Oncogene"},{"issue":"40","key":"299_CR266","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1002\/adma.201506312","volume":"28","author":"C Wang","year":"2016","unstructured":"Wang C, Sun W, Wright G, Wang AZ, Gu Z. Inflammation-triggered cancer immunotherapy by programmed delivery of CpG and anti-PD1 antibody. Adv Mater. 2016;28(40):8912\u201320. https:\/\/doi.org\/10.1002\/adma.201506312.","journal-title":"Adv Mater"},{"key":"299_CR267","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.biomaterials.2018.04.039","volume":"171","author":"X Guan","year":"2018","unstructured":"Guan X, Chen J, Hu Y, Lin L, Sun P, Tian H, et al. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase. Biomaterials. 2018;171:198\u2013206. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.04.039.","journal-title":"Biomaterials"},{"key":"299_CR268","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120114","volume":"252","author":"Y Hu","year":"2020","unstructured":"Hu Y, Lin L, Chen J, Maruyama A, Tian H, Chen X. Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger. Biomaterials. 2020;252: 120114. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120114.","journal-title":"Biomaterials"},{"issue":"4","key":"299_CR269","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1021\/acs.biomac.7b00080","volume":"18","author":"X Guan","year":"2017","unstructured":"Guan X, Guo Z, Wang T, Lin L, Chen J, Tian H, et al. A pH-responsive detachable PEG shielding strategy for gene delivery system in cancer therapy. Biomacromol. 2017;18(4):1342\u20139. https:\/\/doi.org\/10.1021\/acs.biomac.7b00080.","journal-title":"Biomacromol"},{"issue":"12","key":"299_CR270","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1007\/s00262-022-03212-6","volume":"71","author":"AJ Najibi","year":"2022","unstructured":"Najibi AJ, Shih T-Y, Zhang DKY, Lou J, Sobral MC, Wang H, et al. Targeting tumor extracellular matrix activates the tumor-draining lymph nodes. Cancer Immunol Immunother. 2022;71(12):2957\u201368. https:\/\/doi.org\/10.1007\/s00262-022-03212-6.","journal-title":"Cancer Immunol Immunother"},{"key":"299_CR271","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.omto.2018.01.003","volume":"8","author":"AA Al-Zaher","year":"2018","unstructured":"Al-Zaher AA, Moreno R, Fajardo CA, Arias-Badia M, Farrera M, De Sostoa J, et al. Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus. Mol Ther Oncolytics. 2018;8:62\u201370. https:\/\/doi.org\/10.1016\/j.omto.2018.01.003.","journal-title":"Mol Ther Oncolytics"},{"issue":"3","key":"299_CR272","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1158\/1078-0432.CCR-20-2400","volume":"27","author":"J Kiyokawa","year":"2021","unstructured":"Kiyokawa J, Kawamura Y, Ghouse SM, Acar S, Bar\u00e7\u0131n E, Mart\u00ednez-Quintanilla J, et al. Modification of extracellular matrix enhances oncolytic adenovirus immunotherapy in glioblastoma. Clin Cancer Res. 2021;27(3):889\u2013902. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2400.","journal-title":"Clin Cancer Res"},{"key":"299_CR273","doi-asserted-by":"publisher","unstructured":"Vera B, Mart\u00ednez-V\u00e9lez N, Xipell E, Acanda de la Rocha A, Pati\u00f1o-Garc\u00eda A, Saez-Castresana J, et al. Characterization of the antiglioma effect of the oncolytic adenovirus VCN-01. PLoS One. 2016; 11(1):e0147211. https:\/\/doi.org\/10.1371\/journal.pone.0147211.","DOI":"10.1371\/journal.pone.0147211"},{"issue":"6","key":"299_CR274","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/1078-0432.CCR-14-2213","volume":"21","author":"A Rodr\u00edguez-Garc\u00eda","year":"2015","unstructured":"Rodr\u00edguez-Garc\u00eda A, Gim\u00e9nez-Alejandre M, Rojas JJ, Moreno R, Bazan-Peregrino M, Cascall\u00f3 M, et al. Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression. Clin Cancer Res. 2015;21(6):1406\u201318. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2213.","journal-title":"Clin Cancer Res"},{"key":"299_CR275","doi-asserted-by":"publisher","unstructured":"N M-V, E X, B V, A A de la R, M Z, L M, et al. The oncolytic adenovirus VCN-01 as therapeutic approach against pediatric osteosarcoma. Clin Cancer Res. 2016; 22(9). https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1899.","DOI":"10.1158\/1078-0432.CCR-15-1899"},{"issue":"11","key":"299_CR276","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003254","volume":"9","author":"M Bazan-Peregrino","year":"2021","unstructured":"Bazan-Peregrino M, Garcia-Carbonero R, Laquente B, \u00c1lvarez R, Mato-Berciano A, Gimenez-Alejandre M, et al. VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects. J Immunother Cancer. 2021;9(11): e003254. https:\/\/doi.org\/10.1136\/jitc-2021-003254.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"299_CR277","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003255","volume":"10","author":"R Garcia-Carbonero","year":"2022","unstructured":"Garcia-Carbonero R, Bazan-Peregrino M, Gil-Mart\u00edn M, \u00c1lvarez R, Macarulla T, Riesco-Martinez MC, et al. Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors. J Immunother Cancer. 2022;10(3): e003255. https:\/\/doi.org\/10.1136\/jitc-2021-003255.","journal-title":"J Immunother Cancer"},{"key":"299_CR278","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jconrel.2021.02.035","volume":"332","author":"A Mato-Berciano","year":"2021","unstructured":"Mato-Berciano A, Morgado S, Maliandi MV, Farrera-Sal M, Gimenez-Alejandre M, Ginest\u00e0 MM, et al. Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11. J Control Release. 2021;332:517\u201328. https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.035.","journal-title":"J Control Release"},{"issue":"3","key":"299_CR279","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008431","volume":"12","author":"S Wang","year":"2024","unstructured":"Wang S, Li Y, Xu C, Dong J, Wei J. An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy. J Immunother Cancer. 2024;12(3): e008431. https:\/\/doi.org\/10.1136\/jitc-2023-008431.","journal-title":"J Immunother Cancer"},{"key":"299_CR280","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107251","volume":"145","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yu J, Liu M, Xie Z, Lei X, Yang X, et al. Small-molecule modulators of tumor immune microenvironment. Bioorg Chem. 2024;145: 107251. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107251.","journal-title":"Bioorg Chem"},{"issue":"5","key":"299_CR281","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18(5):379\u2013401. https:\/\/doi.org\/10.1038\/s41573-019-0016-5.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"299_CR282","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35(8):1304\u201326. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.004.","journal-title":"Cell Metab"},{"issue":"35","key":"299_CR283","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305150","volume":"10","author":"M Li","year":"2023","unstructured":"Li M, Liu Y, Zhang Y, Yu N, Li J. Sono-Activatable Semiconducting Polymer Nanoreshapers Multiply Remodel Tumor Microenvironment for Potent Immunotherapy of Orthotopic Pancreatic Cancer. Adv Sci (Weinh). 2023;10(35): e2305150. https:\/\/doi.org\/10.1002\/advs.202305150.","journal-title":"Adv Sci (Weinh)"},{"issue":"22","key":"299_CR284","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201734","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, et al. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. Adv Sci (Weinh). 2022;9(22): e2201734. https:\/\/doi.org\/10.1002\/advs.202201734.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"299_CR285","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1111\/jcmm.14356","volume":"23","author":"J Zhou","year":"2019","unstructured":"Zhou J, Wang G, Chen Y, Wang H, Hua Y, Cai Z. Immunogenic cell death in cancer therapy: Present and emerging inducers. J Cell Mol Med. 2019;23(8):4854\u201365. https:\/\/doi.org\/10.1111\/jcmm.14356.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"299_CR286","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1021\/acsabm.0c00299","volume":"3","author":"Q Liu","year":"2020","unstructured":"Liu Q, Sun Y, Yin X, Li J, Xie J, Xie M, et al. Hyaluronidase-Functionalized Silica Nanocarrier for Enhanced Chemo-Immunotherapy through Inducing Immunogenic Cell Death. ACS Appl Bio Mater. 2020;3(5):3378\u201389. https:\/\/doi.org\/10.1021\/acsabm.0c00299.","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"299_CR287","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1021\/acsbiomaterials.0c01394","volume":"7","author":"Z Wang","year":"2021","unstructured":"Wang Z, Xu Y, Wu G, Zuo T, Zhang J, Yang J, et al. Dual-Responsive and Deep-Penetrating Nanomicelles for Tumor Therapy via Extracellular Matrix Degradation and Oxidative Stress. ACS Biomater Sci Eng. 2021;7(1):166\u201379. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c01394.","journal-title":"ACS Biomater Sci Eng"},{"issue":"23","key":"299_CR288","doi-asserted-by":"publisher","first-page":"23568","DOI":"10.1021\/acsnano.3c06544","volume":"17","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang C, Song M, Zhang Z, Zhou J, Zhang H, et al. Enzyme-Silenced Nanosponges Prolong Intratumoral Lifetime to Facilitate Intercellular Relay Drug Delivery and Treatment Efficacy. ACS Nano. 2023;17(23):23568\u201383. https:\/\/doi.org\/10.1021\/acsnano.3c06544.","journal-title":"ACS Nano"},{"issue":"25","key":"299_CR289","doi-asserted-by":"publisher","first-page":"00164","DOI":"10.1016\/j.scib.2025.02.005","volume":"S2095\u20139273","author":"M Geng","year":"2025","unstructured":"Geng M, Du H, Wei X, Chen S, Cheng J, Meng S, et al. Engineered platelets-based nano-aircraft system for precise tumor chemo-immunotherapy with graded drug delivery and self-recognized tumor targeting. Sci Bull (Beijing). 2025;S2095\u20139273(25):00164\u201371. https:\/\/doi.org\/10.1016\/j.scib.2025.02.005.","journal-title":"Sci Bull (Beijing)"},{"issue":"13","key":"299_CR290","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/JCO.18.01295","volume":"37","author":"RK Ramanathan","year":"2019","unstructured":"Ramanathan RK, McDonough SL, Philip PA, Hingorani SR, Lacy J, Kortmansky JS, et al. Phase IB\/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313. J Clin Oncol. 2019;37(13):1062\u20139. https:\/\/doi.org\/10.1200\/JCO.18.01295.","journal-title":"J Clin Oncol"},{"key":"299_CR291","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.760763","volume":"13","author":"L Brennan","year":"2022","unstructured":"Brennan L, Brouwer-Visser J, N\u00fcesch E, Karpova M, Heller A, Gaire F, et al. T-Cell Heterogeneity in Baseline Tumor Samples: Implications for Early Clinical Trial Design and Analysis. Front Immunol. 2022;13: 760763. https:\/\/doi.org\/10.3389\/fimmu.2022.760763.","journal-title":"Front Immunol"},{"key":"299_CR292","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111218","volume":"120","author":"J Wang","year":"2024","unstructured":"Wang J, Ruan S, Yu T, Meng X, Ran J, Cen C, et al. Upregulation of HAS2 promotes glioma cell proliferation and chemoresistance via c-myc. Cell Signal. 2024;120: 111218. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111218.","journal-title":"Cell Signal"},{"issue":"7","key":"299_CR293","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11912-017-0608-3","volume":"19","author":"KM Wong","year":"2017","unstructured":"Wong KM, Horton KJ, Coveler AL, Hingorani SR, Harris WP. Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20). Curr Oncol Rep. 2017;19(7):47. https:\/\/doi.org\/10.1007\/s11912-017-0608-3.","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"299_CR294","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/oncolo\/oyad022","volume":"28","author":"AH Ko","year":"2023","unstructured":"Ko AH, Kim K-P, Siveke JT, Lopez CD, Lacy J, O\u2019Reilly EM, et al. Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib\/II Umbrella Randomized Study Platform. Oncologist. 2023;28(6):553-e472. https:\/\/doi.org\/10.1093\/oncolo\/oyad022.","journal-title":"Oncologist"},{"issue":"6648","key":"299_CR295","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/s0140-6736(51)93361-2","volume":"1","author":"JN Thorpe","year":"1951","unstructured":"Thorpe JN. Procaine with hyaluronidase as local anesthetic. Lancet. 1951;1(6648):210\u20131. https:\/\/doi.org\/10.1016\/s0140-6736(51)93361-2.","journal-title":"Lancet"},{"issue":"7","key":"299_CR296","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1524-4725.2010.01585.x","volume":"36","author":"A Lee","year":"2010","unstructured":"Lee A, Grummer SE, Kriegel D, Marmur E. Hyaluronidase. Dermatol Surg. 2010;36(7):1071\u20137. https:\/\/doi.org\/10.1111\/j.1524-4725.2010.01585.x.","journal-title":"Dermatol Surg"},{"issue":"11","key":"299_CR297","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jcrs.2008.07.022","volume":"34","author":"M Remy","year":"2008","unstructured":"Remy M, Pinter F, Nentwich MM, Kampik A, Sch\u00f6nfeld C-L. Efficacy and safety of hyaluronidase 75 IU as an adjuvant to mepivacaine for retrobulbar anesthesia in cataract surgery. J Cataract Refract Surg. 2008;34(11):1966\u20139. https:\/\/doi.org\/10.1016\/j.jcrs.2008.07.022.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"299_CR298","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7181\/acfs.2017.01396","volume":"19","author":"JH Han","year":"2018","unstructured":"Han JH, Kim J, Yoon KC, Shin HW. Treatment of post-traumatic hematoma and fibrosis using hyaluronidase injection. Arch Craniofac Surg. 2018;19(3):218\u201321. https:\/\/doi.org\/10.7181\/acfs.2017.01396.","journal-title":"Arch Craniofac Surg"},{"issue":"2","key":"299_CR299","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jconrel.2006.05.027","volume":"114","author":"LH Bookbinder","year":"2006","unstructured":"Bookbinder LH, Hofer A, Haller MF, Zepeda ML, Keller G-A, Lim JE, et al. A recombinant human enzyme for enhanced interstitial transport of therapeutics. J Control Release. 2006;114(2):230\u201341. https:\/\/doi.org\/10.1016\/j.jconrel.2006.05.027.","journal-title":"J Control Release"},{"issue":"6","key":"299_CR300","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00266-022-03207-9","volume":"48","author":"A Borzabadi-Farahani","year":"2024","unstructured":"Borzabadi-Farahani A, Mosahebi A, Zargaran D. A scoping review of hyaluronidase use in managing the complications of aesthetic interventions. Aesth Plast Surg. 2024;48(6):1193\u2013209. https:\/\/doi.org\/10.1007\/s00266-022-03207-9.","journal-title":"Aesth Plast Surg"},{"issue":"7","key":"299_CR301","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jamadermatol.2018.0515","volume":"154","author":"M Alam","year":"2018","unstructured":"Alam M, Hughart R, Geisler A, Paghdal K, Maisel A, Weil A, et al. Effectiveness of low doses of hyaluronidase to remove hyaluronic acid filler nodules: A randomized clinical trial. JAMA Dermatol. 2018;154(7):765\u201372. https:\/\/doi.org\/10.1001\/jamadermatol.2018.0515.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"299_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188931","volume":"1878","author":"Y Teng","year":"2023","unstructured":"Teng Y, Chen Y, Tang X, Wang S, Yin K. PAD2: A potential target for tumor therapy. Biochim Biophys Acta Rev Cancer. 2023;1878(5): 188931. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188931.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"299_CR303","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/SCS.0000000000006042","volume":"31","author":"SK Kim","year":"2020","unstructured":"Kim SK, Yang JY, Kim CW, Baek SH, Kim U, Hwang E. The Effect of Hyaluronidase on the Fat Graft. J Craniofac Surg. 2020;31(3):618\u201321. https:\/\/doi.org\/10.1097\/SCS.0000000000006042.","journal-title":"J Craniofac Surg"},{"issue":"4","key":"299_CR304","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5999\/aps.2020.00752","volume":"47","author":"H Jung","year":"2020","unstructured":"Jung H. Hyaluronidase: An overview of its properties, applications, and side effects. Arch Plast Surg. 2020;47(4):297\u2013300. https:\/\/doi.org\/10.5999\/aps.2020.00752.","journal-title":"Arch Plast Surg"},{"issue":"8","key":"299_CR305","first-page":"E69","volume":"14","author":"G Murray","year":"2021","unstructured":"Murray G, Convery C, Walker L, Davies E. Guideline for the Safe Use of Hyaluronidase in Aesthetic Medicine, Including Modified High-dose Protocol. J Clin Aesthet Dermatol. 2021;14(8):E69-75.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"299_CR306","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/14764172.2015.1007069","volume":"17","author":"MS Kim","year":"2015","unstructured":"Kim MS, Youn S, Na CH, Shin BS. Allergic reaction to hyaluronidase use after hyaluronic acid filler injection. J Cosmet Laser Ther. 2015;17(5):283\u20135. https:\/\/doi.org\/10.3109\/14764172.2015.1007069.","journal-title":"J Cosmet Laser Ther"},{"issue":"7","key":"299_CR307","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.bjps.2021.03.125","volume":"74","author":"DSC Sharma","year":"2021","unstructured":"Sharma DSC, Lahiri MA. Use of hyaluronidase in plastic surgery: A review. J Plast Reconstr Aesthet Surg. 2021;74(7):1610\u20134. https:\/\/doi.org\/10.1016\/j.bjps.2021.03.125.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"2","key":"299_CR308","doi-asserted-by":"publisher","first-page":"127e","DOI":"10.1097\/PRS.0b013e3182a4c282","volume":"133","author":"SH Bailey","year":"2014","unstructured":"Bailey SH, Fagien S, Rohrich RJ. Changing Role of Hyaluronidase in Plastic Surgery. Plast Reconstr Surg. 2014;133(2):127e-e132. https:\/\/doi.org\/10.1097\/PRS.0b013e3182a4c282.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"299_CR309","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00266-023-03348-5","volume":"48","author":"G Guliyeva","year":"2024","unstructured":"Guliyeva G, Huayllani MT, Kraft C, Lehrman C, Kraft MT. Allergic Complications of Hyaluronidase Injection: Risk Factors, Treatment Strategies, and Recommendations for Management. Aesthetic Plast Surg. 2024;48(3):413\u201339. https:\/\/doi.org\/10.1007\/s00266-023-03348-5.","journal-title":"Aesthetic Plast Surg"},{"issue":"8","key":"299_CR310","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1177\/1090820X13511970","volume":"33","author":"M Cavallini","year":"2013","unstructured":"Cavallini M, Gazzola R, Metalla M, Vaienti L. The Role of Hyaluronidase in the Treatment of Complications From Hyaluronic Acid Dermal Fillers. Aesthet Surg J. 2013;33(8):1167\u201374. https:\/\/doi.org\/10.1177\/1090820X13511970.","journal-title":"Aesthet Surg J"},{"issue":"10","key":"299_CR311","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/DSS.0000000000000123","volume":"40","author":"EC Keller","year":"2014","unstructured":"Keller EC, Kaminer MS, Dover JS. Use of hyaluronidase in patients with bee allergy. Dermatol Surg. 2014;40(10):1145\u20137. https:\/\/doi.org\/10.1097\/DSS.0000000000000123.","journal-title":"Dermatol Surg"},{"key":"299_CR312","doi-asserted-by":"publisher","DOI":"10.2196\/50403","volume":"7","author":"G Kroumpouzos","year":"2024","unstructured":"Kroumpouzos G, Treacy P. Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. JMIR Dermatol. 2024;7: e50403. https:\/\/doi.org\/10.2196\/50403.","journal-title":"JMIR Dermatol"},{"issue":"5","key":"299_CR313","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1208\/s12248-015-9782-0","volume":"17","author":"S Rosengren","year":"2015","unstructured":"Rosengren S, Dychter SS, Printz MA, Huang L, Schiff RI, Schwarz H-P, et al. Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration. AAPS J. 2015;17(5):1144\u201356. https:\/\/doi.org\/10.1208\/s12248-015-9782-0.","journal-title":"AAPS J"},{"issue":"6","key":"299_CR314","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1208\/s12248-022-00757-3","volume":"24","author":"MA Printz","year":"2022","unstructured":"Printz MA, Sugarman BJ, Paladini RD, Jorge MC, Wang Y, Kang DW, et al. Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration. AAPS J. 2022;24(6):110. https:\/\/doi.org\/10.1208\/s12248-022-00757-3.","journal-title":"AAPS J"},{"issue":"11","key":"299_CR315","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1158\/1535-7163.MCT-10-0470","volume":"9","author":"CB Thompson","year":"2010","unstructured":"Thompson CB, Shepard HM, O\u2019Connor PM, Kadhim S, Jiang P, Osgood RJ, et al. Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models. Mol Cancer Ther. 2010;9(11):3052\u201364. https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0470.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"299_CR316","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/2047-783X-19-30","volume":"19","author":"S Hilton","year":"2014","unstructured":"Hilton S, Schrumpf H, Buhren BA, B\u00f6lke E, Gerber PA. Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients. Eur J Med Res. 2014;19(1):30. https:\/\/doi.org\/10.1186\/2047-783X-19-30.","journal-title":"Eur J Med Res"},{"issue":"5","key":"299_CR317","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00132-024-04493-8","volume":"53","author":"RH Tolba","year":"2024","unstructured":"Tolba RH. Current regulations in the Animal Welfare Act and the significance for animal research. Orthopadie (Heidelb). 2024;53(5):336\u201340. https:\/\/doi.org\/10.1007\/s00132-024-04493-8.","journal-title":"Orthopadie (Heidelb)"},{"issue":"1","key":"299_CR318","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1517\/14712590903490382","volume":"10","author":"AL Dunn","year":"2010","unstructured":"Dunn AL, Heavner JE, Racz G, Day M. Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management. Expert Opin Biol Ther. 2010;10(1):127\u201331. https:\/\/doi.org\/10.1517\/14712590903490382.","journal-title":"Expert Opin Biol Ther"},{"issue":"20","key":"299_CR319","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00299-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T23:03:04Z","timestamp":1752274984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00299-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":319,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00299-y","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors state that there are no potential competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}